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ABSTRACT 
 
Older adults are among the fastest-growing segment of the world’s population. In 
Costa Rica, life expectancy is comparable to developed countries, such as the United 
States and Western European countries. The loss of cognitive capacity is one of the most 
significant issues affecting the quality of life of older adults and their families. Although 
the causes of cognitive decline remain uncertain, it has been linked to cardiovascular risk 
factors such as diabetes mellitus and high blood pressure. Dietary fatty acids have an 
important role in these conditions, making it is plausible that they could play a role in 
cognitive deterioration  
The purpose of this research is to examine the association among fatty acid intake, 
lipid profile, and cognitive health in Costa Rican elders. To examine these issues, a cross-
sectional secondary data analysis was performed using public data from the Costa Rican 
Longevity and Healthy Aging Study, a nationally representative longitudinal survey of 
health and socioeconomic indicators of Costa Rican residents ages 60 and over in 2005 
(n=2878). All data and specimens in the study were collected at the participants’ homes, 
usually during two visits. Diet information was collected using a semi-quantitative food 
frequency questionnaire. Cognitive disability was assessed with an adaptation of the 
Mini-Mental State Examination (MMSE). Participants who answered the 15 items with 
fewer than 75% correct answers were considered to be ―cognitively impaired.‖ Serum 
lipid analyses were conducted by nationally certified laboratories. General characteristics 
between cognitively disabled and non-cognitively disabled participants were explored 
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using descriptive statistics. Regression models were controlled for age, caloric intake, and 
lipid medication. 
The study found highly significant differences between cognitively disabled and 
non-cognitively disabled older adults. The demographic data indicated that adults with 
less than 75% accuracy on the MMSE were younger, had lower monthly income, and had 
completed fewer years of formal education. Important differences were also found in the 
health profile. Medical diagnoses of diabetes, stroke, and heart attack were significantly 
higher among the cognitively disabled. Non-cognitively disabled adults had a higher rate 
of medical diagnosis of dyslipidemia and presented a higher rate of metabolic syndrome. 
Anthropometric data confirmed that cognitively disabled elders had a lower BMI, lower 
body weight, and higher percentage of underweight. The dietary analysis revealed a 
lower energy, total fat, and monounsaturated fatty acids intake compared to their 
counterparts. The lipid profile from adults who were not cognitively disabled indicated 
significantly higher levels of LDL, triacylglycerides, and total cholesterol. The multiple 
regression analysis suggested a significant (p<.050), yet weak (R
2
=.299), association 
between MMSE score and serum lipid profile as well as dietary fatty acids.  
Differences in Costa Rican elders’ demographic, health, and diet characteristics 
were found between cognitively disabled individuals and those not disabled. Dietary fat 
intake and serum lipid profile were weakly associated with cognitive outcomes. Further 
research, particularly longitudinal studies, are needed to better examine this relationship. 
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CHAPTER ONE 
INTRODUCTION 
 
Older adults are among the fastest growing segments of the world population. The 
number and proportion of this population is increasing in both developing and developed 
countries; by 2015 people aged 65 or older will outnumber children under the age of five 
(World Health Organization, National Institute of Aging &  National Institute of Health, 
2011). Currently, in the entire world population, one out of every ten persons is over 60 
years old (United Nations Population Fund, 2010). By 2025, the proportion of older 
adults is expected to reach 25% in North America, 21% in Eastern Asia, 14% in Latin 
America and 11% in South and Central Asia (United Nations Population Division, 
2001).The majority of older people over the age of 60 years now live in developing 
countries, where the most rapid demographic changes are occurring, with predicted 
increases of 200-400 percent in their older populations during the next decades (WHO, 
2000). 
Mortality rates have declined due to improvement in social development, living 
standards, hygiene, sanitation and infectious disease prevention (United Nations 
Population Division, 2001).  Life expectancy in the U.S. has increased from 47 years, for 
Americans born in 1900, to 77 years, for those born in 2001 (Centers for Disease Control 
and Prevention & The Merck Company Foundation, 2007). Recent data, establishes a life 
expectancy of 76 years for males and 81 years for females (CDC & National Center for 
Health Statistics, 2011). In low income countries, life expectancy has increased from 45 
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years in the 1950s to 64 years in the 1960s (UNPD, 2001).  Additionally, fertility rates 
have fallen all over the world, mainly due to the development of effective contraceptive 
methods and improvements in women’s education (WHO, 2000). 
Increases in longevity and the proportion of people over the age of 60 years, is 
often regarded as a challenge to health systems as longer lives are commonly associated 
with a prevalence of disease (WHO, 2000). The leading causes of death have shifted 
dramatically from infectious diseases to non-communicable, chronic diseases and from 
younger to older individuals (UNPD, 2001).  Disabilities associated with chronic illness 
also increase with advancing age (CDC, 2011).  
The medical conditions most frequently encountered in this age group include 
cardiovascular disease, osteoarthritis, osteoporosis, depression, diabetes, sensory deficits, 
cognitive decline, and dementia (CDC & The Merck Company Foundation, 2007). The 
loss of cognitive capacity is one of the most important factors affecting the quality of life 
of older adults and their families and it is one of the main reasons that people are 
admitted into nursing homes (Gaugler, Duval, Anderson & Kane, 2007).  
Most experts agree that the components of healthy cognitive function include 
language, thought, memory, executive function (the ability to plan and carry out tasks), 
judgment, attention, perception, remembered skills (such as driving) and the ability to 
live a purposeful life (National Research Council, 2000).  Cognitive health is not limited 
to the absence of disease, it can range from optimal functioning, slight cognitive 
impairment, to severe dementia (Hendrie et al., 2006).   
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As the population ages, it is important to understand the influence of modifiable 
lifestyle factors such as diet on lifespan,  as well as ―healthspan‖, including cognitive, 
mental and physical health maintenance into advanced age. The causes of cognitive 
decline remain uncertain; however they have been linked to cardiovascular disease and 
cardiovascular risk factors such as diabetes mellitus and high blood pressure (Naqvi et 
al., 2011). 
Dietary fatty acids have an important role in cardiovascular disease, thus it is 
plausible that they could have a role in cognitive deterioration (Hunter, Zhang & Kris-
Etherton, 2009). Fatty acids could be involved through several mechanisms; including 
atherosclerosis, thrombosis, and inflammation (Kalmijn, 2000).   
There has been increasing interest in the hypothesis that fish consumption, 
polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) could play a protective role against cognitive decline. However, evidence of 
this relationship remains controversial. Results are also inconsistent in large cross-
sectional studies focused on dietary intake, particularly fish and marine PUFA.  Findings 
from longitudinal data are less controversial; but still disputed (Carpurso et al., 2003; 
Morris et al., 2004). Several studies suggested that an increase of saturated fats could 
have negative effects on cognitive health (Kalmijn, Feskens, Launer & Kromhout, 1997; 
Freeman, Haley-Zitlin, Stevens & Granholm, 2011) while PUFA and monounsaturated 
fatty acids (MUFA) may have a protective effect (Capurso et al., 2003; Solfrizzi et al., 
1999). Except for reports from an ongoing Chilean study (Hirsch, de la Maza, Barrera, 
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Gattas, Petermann & Bunout, 2002), there are no known studies on this topic in Latin 
American countries or developing nations. 
 
1.1 Statement of Purpose 
The aim of this research is to determine the association between diet, serum lipids 
and cognitive health in older adults.  
 
1.2 Research Questions 
This thesis will explore two research questions and hypotheses on the relationship 
of diet and nutrition to cognitive health by using secondary cross-sectional data from a 
population of Costa Rican older adults.  
 
1. What is the relationship between fatty acid intake and cognitive health in Costa 
Rican elders? 
Hypothesis (H1): PUFA, particularly n-3 and n-6, will have a protective effect on 
cognitive health.  
 
2. Is there an association between serum lipid profile and cognitive health in Costa 
Rican elders? 
Hypothesis (H2): A desirable serum lipid profile will have a protective effect on 
cognitive health. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
The average life expectancy in Costa Rica is 79 years: 77 years for men and 81 
years for women (World Health Organization, 2009). This is the highest life expectancy 
in Latin America. When compared to life expectancy in the region the gap is even 
broader: Central American countries report a life expectancy ranging from 69 years in 
Guatemala and El Salvador to 74 years in Panama. Costa Rican life expectancy is 
comparable to that of developed countries such as the United States and Western 
European countries. In addition, compared to adult men over 60 years old, Costa Rican 
males have a longer life expectancy than white males in the United Stated (Brenes-
Camacho & Rosero-Bixby, 2009; Rosero-Bixby, 1995). For men over 90 years old, life 
expectancy is one-half year more in Costa Rica than in any other country (Rosero-Bixby, 
2008). Comparisons with the United States and Sweden show that the Costa Rican 
advantage comes mostly from a reduced incidence of cardiovascular diseases, coupled 
with a low prevalence of obesity (Rosero-Bixby & Dow, 2009). Of added importance to 
this comparison, is the fact that the Costa Rican Gross National Product is a small 
fraction of the Gross National Product for the United States or Western European 
countries (United Nations, 2009a).  
The Costa Rican Social Security system is one important factor for the Costa 
Rican high life expectancy (de Bertodano, 2003; Rosero-Bixby, 2004a). While private 
health care is available, most health services since 1941 have been provided by the Costa 
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Rican social security system, known as Caja Costarricense del Seguro Social (CCSS). 
This system is funded from individual payroll deductions, contributions from the 
employers, and the government. Those who contribute to the CCSS are entitled to health 
insurance that allows them and their family to receive free health care services and 
medications at any public hospital, clinic or community health (Brenes-Camacho & 
Rosero-Bixby, 2008). The CCSS covers about 90% of the population including 9% of the 
individuals whose insurance is paid by the government. These percentages are higher 
among the elderly where 95% are covered and up to 22% have voluntary government-
covered insurance (Rosero-Bixby, 2004b). People who consistently declare themselves as 
uninsured (10% of total population, 5% of the elderly) can still obtain health care from 
the CCSS units for a fee or for free if institutional social workers verify that the patients 
have no means to pay for health care services (de Bertodano, 2003).  
Analyses of data from developed countries have found socioeconomic status 
(SES) and adult health to be significantly positively correlated with better health at higher 
SES (Seeman, Merkin, Crimmins, Koretz, Charette, & Karlamangla, 2008). Differences 
in SES and use of preventive health care services in older adults have also revealed SES 
disparities in health service utilization. People with higher SES were more likely to take 
advantage of most preventive services and utilization rates among uninsured seniors were 
lower than among their insured peers (Brenes-Camacho & Rosero-Bibxy, 2009). In 
contrast, research on both mortality and metabolic syndrome among Costa Ricans reveals 
that those who are better educated and wealthier are worse than those with lower SES 
strata. Nevertheless, quality-of-life related measures such as functional and cognitive 
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disabilities, physical frailty, and depression all clearly worsen with lower SES (Rosero-
Bixby & Dow, 2009).  
In some developed countries, an association of lower educational attainment with 
greater risk of mortality has been found (Kunitz, 2007) although in Costa Rica there are 
relatively minor associations between mortality and education among those aged 60 and 
above (Rosero-Bixby, Dow & Lacle, 2005). In contrast, a recent analysis in the United 
States of similarly aged individuals revealed substantial differentials by education, with 
mortality rates 5-6% higher per year for each year less of education (Steenland, Henley & 
Thun, 2002). To explore this association, data from older adults participating in National 
Health and Nutrition Examination Survey (NHANES) was compared to data from the 
Costa Rican Longevity and Healthy Aging Study (CRELES, or Costa Rica Estudio de 
Longevidad y Envejecimiento Saludable). Results indicate significantly lower hazardous 
levels of risk biomarkers at higher levels of education for more than half of the risk 
factors in the United States as compared with less than a third of the outcomes in Costa 
Rica (Rehkopf, Dow & Rosero-Bixby, 2009). 
To determine the relationship between socialized health care and longevity, 
research has been conducted to explore the relationship between longevity and chronic 
disease management by both CCSS and private health care. In one study, the metabolic 
control of diabetes in community health care centers, regional clinics and hospitals, and a 
subsample of 542 CRELES participants with self-reported diabetes mellitus was 
assessed. Except for elevated levels of triacylglycerides and low density lipoproteins 
(LDL) in patients from community health centers, no statistical differences in the other 
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metabolic control indicators were seen across health care settings (Brenes-Camacho & 
Rosero-Bixby, 2008). Levels of metabolic control among elderly people with diabetes 
mellitus were found to be similar to those observed in industrialized countries (Brenes-
Camacho & Rosero-Bixby, 2008). 
A similar study of Costa Rican older adults, from this same data set, examined the 
prevalence, hypertension unawareness and treatment by demographic variables and found 
gender differences in prevalence, condition unawareness, and treatment with odds of 
being treated higher in educated individuals (Mendez-Chacon, Santamaria-Ulloa & 
Rosero-Bixby, 2008). 
 
2.1 Allostatic Load 
A framework which has gained popularity in the study of ageing and longevity is 
the allostatic load. Allostasis means ―maintaining stability (or homeostasis) through 
change‖; the concept was proposed by McEwen and Stellar (1993) to refer to wear and 
tear on the body. The allostatic load suggests that resting levels of the neuroendocrine 
markers become dysregulated through stress experienced over time. 
The two main hypotheses established related to this subject, are that allostatic 
load is a measure of physiological dysregulation; and that allostatic load is a risk factor 
for morbidity and mortality (Seeman, Singer, Rowe, Horwitz, & McEwen, 1997). Both 
theories have been examined when looking at the unusually high longevity in Costa Rica. 
Results from this analysis were contrary to these hypotheses, since stressors were not 
associated with individual biomarker levels and levels of neuroendocrine allostatic 
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indicators (cortisol dehydroepiandrosterone sulfate, epinephrine, and norepinephrine) 
(Gersten, Dow & Rosero-Bixby, 2010).  
There are some relatively new findings about the differentials and determinants of 
aging and longevity, particularly in developing countries. Although research on the 
impact of diet and supplementation in aging and longevity has been conducted in 
developed nations, little is known about the populations from developing countries.  
 
2.2 Cardiovascular Disease and Fatty Acids 
In 2008, chronic diseases accounted for 63% of the 57 million estimated deaths 
worldwide (WHO, 2010). In Costa Rica, during the 1970s, health indicators such life 
expectancy, infant mortality, health coverage and sanitation showed a noteworthy 
improvement (Rosero-Bixby, 1996). Death rates from infectious diseases declined 
sharply and rates of mortality from cardiovascular disease increased. Since then, 
cardiovascular disease, particularly myocardial infarction became the leading cause of 
deaths among Costa Rican adults (Rosello-Araya & Guzman-Padilla, 2004). Since the 
leading causes of death are linked to diet and other modifiable risk factors it is logical to 
think that these play a decisive role in aging and longevity. 
Lipids are organic compounds that are insoluble in water and soluble in organic 
substances such as ether, acetone and chloroform (Jones & Kubow, 1998). They are 
important constituents of the diet due to their high energy value (9 kcal/g), but also 
because fat soluble vitamins and essential fatty acids are natural components of foods 
(Gurr, Harwood & Frayn, 2002). 
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Fats, a subgroup of lipids, are carboxylic esters derived from a single alcohol, 
glycerol, to which three fatty acids are attached. More specifically, the molecule is called 
triacylglycerol. Fatty acids linked to the glycerol portion of the triacylglycerol may vary 
in length of the carbon chain, degree of saturation and the spatial configuration (Gurr et 
al., 2002). 
Fatty acids may be long-chain monocarboxylic acids. They usually contain an 
even number of carbon atoms, usually between 12 and 24. The chemical properties of 
fatty acids are derived from the coexistence of a carboxyl group and a hydrocarbon chain 
(Gurr et al., 2002).When all the hydrogen atoms of a fatty acid are bonded to carbon 
atoms, it is saturated. In turn, a fatty acids is unsaturated when there are one or more 
double bonds between carbon atoms, thus decreasing the number of hydrogen atoms that 
are bound (Jones & Kubow, 1998). 
Double bonds between carbon atoms of an unsaturated fatty acid may have 
different configurations depending on the spatial orientation of the hydrogen atoms 
bonds. These configurations are called cis or trans, depending on whether the two 
hydrogen atoms are oriented in the same (cis) or in the opposite direction (trans) to the 
plane as defined by the double bond between carbons (Jones & Kubows, 1998). 
Usually, in nature, the unsaturated fatty acid is cis oriented. This means the 
provision of the molecule is angled, with the vertex at the unsaturation. This spatial 
configuration causes the melting points of the unsaturated acids to be lower than the 
saturated counterparts. In contrast, the double bonds in the trans fatty acids (TFA) distort 
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the crystal symmetry, making it very similar to the saturated fatty acids and increasing its 
melting point (Gurr et al., 2002). 
Some fatty acids cannot be synthesized by higher animals (including humans), 
and because its biological function is essential, it must be supplied in the diet. For this 
reason they are called essential fatty acids (Gurr et al., 2002). The consumption of an 
adequate intake of fatty acids, in addition to meeting the needs of energy and essential 
fatty acids helps to reduce the risk of cardiovascular disease. In the 1970s, the classic 
diet-heart hypothesis was proposed to explain the relationship between diet and 
cardiovascular disease risk (Hu & Willet, 2001). 
 
2.2.1 n-6 Polyunsaturated fatty acids (n-6 PUFA) 
The classic studies of Keys, Anderson and Grande (1965) and Hegsted, 
McGandy, Myers and Stare (1965) indicated that the both polyunsaturated and 
monounsaturated fatty acids had a neutral effect on serum cholesterol levels. However, 
current evidence has shown otherwise, corroborated by metabolic studies that n-6 PUFA 
decrease serum cholesterol (Ascherio, 2002). A compilation of several metabolic studies 
showed that vegetable oils, rich in linolenic acid (primary n-6 PUFA), have a strong 
cholesterol-lowering effect when they replace saturated fatty acids (SFA) it in the diet 
(Grundy et al., 1982). This coincides with the results of dietary intervention trials which 
showed that diets high in n-6 PUFA (17% energy intake), compared with diets low in fat 
(<30% energy intake) and high in carbohydrates (>60% energy intake), are more 
effective in lowering serum cholesterol levels and mortality rates of cardiovascular 
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disease (Sacks & Katan, 2002). Similarly, prospective cohort studies have shown an 
inverse association between intake of linoleic acid and risk of coronary heart disease (Hu, 
Mason & Willet, 2001). 
In addition to its effect on serum cholesterol, linoleic acid appears to have other 
beneficial effects on cardiovascular disease. In the Nurses' Health Study (Salmeron et al., 
2001), a high consumption of marine n-6 PUFA was associated with a significantly lower 
incidences of type 2 diabetes, as this may improve sensitivity to insulin. Additionally, 
animal studies have suggested an antiarrhythmic effect from sunflower oil, which is rich 
in linoleic acid, although it is less than the effect generated by fish oil (Hu et al., 2001). 
Other studies have shown that the addition of a high amount of linoleic acid to a 
diet low in SFA lowers serum cholesterol levels by 15% which significantly reduces the 
risk of cardiovascular disease. Many controlled trials have shown that a 1% reduction in 
total serum cholesterol and LDL causes a decrease of about 1.5% in the incidence of 
cardiovascular disease (Renaud & Lanzmann-Petithory, 2001). 
In response to the considerable scientific evidence showing the strong cholesterol-
lowering effect of linolenic acid, dietary recommendations in the 1970s and 1980s 
strongly encouraged the consumption of this fatty acid. However, subsequent studies 
showed that an intake of linolenic acid greater than 10% of total energy intake, reduced 
concentrations of high density lipoprotein (HDL) (Rubio, 2002) leading to a  pro-
thrombotic and pro-aggregatory physiological state, characterized by increased blood 
viscosity, vasospasm, vasoconstriction and reduced bleeding time (Simopoulos, 1999). 
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2.2.2 n-3 Polyunsaturated fatty acids (n-3 PUFA) 
Of the n-3 PUFA, α-linolenic acid (C18:3n-3) is the most abundant in the diet and 
is found mainly in linseed oil (51%), canola (9%) and flaxseed oil, walnut oil and 
soybean (7%). It is also found in small amounts in nuts, dairy products, beans, broccoli 
and green leafy vegetables (Rubio, 2002). 
The n-3 PUFA long-chain Eicosapentaenoic acid (EPA) (C20:5n-3) and 
Docosahexaenoic acid (DHA) (C22:6n-3) are found in small amounts in the diet coming 
mainly from high-fat fish such as mackerel (2.5%), salmon (1.2%), sardines (1.2%), tuna 
(0.4%) and halibut (0.4%), although it may be synthesized in humans from α-linolenic 
acid (Simopoulus, 1991). 
Several epidemiological studies have examined the association between 
consumption of n-3 PUFA and risk of cardiovascular disease. In the Multiple 
Intervention Trial Risk Factors, men in the highest quintile of α-linolenic acid 
consumption showed a risk of cardiovascular disease 40% lower than in men in the lower 
quintiles of consumption (Dolecek, 1992). This coincides with the results of the Study of 
Health Professionals Follow-up (Ascherio et al., 1996) which associated a 1% increase in 
the consumption of α-linolenic acid acid with 40% lower risk of fatal cardiovascular 
disease. Likewise, the Finnish Study for Cancer Prevention with Alpha Tocopherol and 
Beta Carotene, revealed that men in higher quintiles of consumption of α-linolenic acid 
had 25% reduction in cardiovascular disease mortality (Pietinen et al., 1997). 
In Costa Rica, Baylin, Kabagambe, Ascherio, Spiegelman and Campos (2003) 
showed an inverse association between levels of α-linolenic acid in adipose tissue and 
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nonfatal myocardial infarction. The risk of myocardial infarction was 63% lower in those 
subjects in the highest quintile of linoleic in adipose tissue than those in the lowest 
quintile. Additional population studies have demonstrated the protective effect of α-
linolenic acid in the prevention of myocardial infarction (Ascherio et al., 1996; Djousse 
et al., 2004; Guallar et al., 1999) whereas other studies have found an increased risk from 
the intake of α-linolenic acid acid (Oomen et al., 2001a; Pedersen et al., 2000). 
One possible explanation for these results is that α-linolenic acid and TFA come 
from similar sources, so it is difficult to distinguish their antagonistic effect. In the 
Cancer Prevention Study with Alpha Tocopherol and Beta Carotene, a clear association 
was evident only after adjustments for the intake of TFA (Pientinen et al., 1997). In 
addition, the association reported by Baylin et al (2003), was strengthened after 
adjustments for these fatty acids. Another viable explanation is that the cardioprotective 
effect of α-linolenic acid is higher in places like Costa Rica, where there is less 
consumption of fish species rich in EPA and DHA (Baylin et al., 2003). 
The protective effect of α-linolenic acid can be achieved by direct action or 
mediated by its conversion to EPA and DHA (Connor, 2002). The mechanism of action is 
unclear, but among the potential biological effects are the reduction of plasma levels of 
triglyacylcerides and Very Low Density Lipoprotein (VLDL) in both normal subjects and 
those with hypertriglyceridemia, although the effect is higher in the latter (Djousse et al., 
2004; Connor, 2002). Similarly, one of the most noticeable effects of n-3 PUFA, is the 
ability to prevent cardiac arrhythmias by the modulation of sodium, potassium, and L-
type calcium channels, inhibition of thromboxane production and by reducing the 
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concentration of non-esterified fatty acids in plasma and cell membranes which are 
believed to have pro-arrhythmic effects (Albert et al., 2002). 
 
2.2.3 n-6 and-3 PUFA Ratio 
In Western diets, high intake of n-6 PUFA has created an imbalance, with respect 
to the intake of n-3 PUFA, to the extent that the relationship of n-6:n-3 in Western diets 
ranges between 15-20: 1. It has been suggested that diets should maintain a relationship 
between the intake of n-6 and n-3 PUFAs of 4:1 or less. Both n-6 and n-3 are primary 
components in the production of eicosanoids. There is a competition among the two 
families of fatty acids for the enzymes involved in the conversion of α-linolenic acid and 
linolenic acid to EPA (Renaud & Lanzmann-Petithory, 2001; Simopoulus, 1999). In the 
Nurse’s Health Study it was evident that there was a modest reduction in cardiovascular 
disease risk when the ratio of α-linolenic acid to linolenic acid was greater than 0.10 
(1:10) (Hu et al., 2001). 
To improve the n-6/n-3 ratio some have proposed to promote the reduction of n-6 
PUFAs. However, considering the significant cardio protective effect of them, the most 
viable solution seems to be replacing animal fat with vegetable oils, which contain 
both poly and monounsaturated fatty acids (Hu et al., 2001). This replacement can also 
increase consumption of n-3 PUFA, for various oils including canola and soybean have a 
significant content of ALA (Connor, 2002). Moreover, the consumption of at least two 
servings of fish per week may increase the amount of n-3 in the diet to achieve a ratio of 
n-3: n-6 without sacrificing desirable benefit of  n-6 PUFA (Hu et al., 2001). 
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2.2.4 Trans Fatty Acids (TFA) 
Oils rich in α-linolenic acid and linolenic acid, because of their susceptibility to 
oxidation, are often hydrogenated during processing, making the cis fatty acids in TFA. 
Functionally, these fatty acids act as SFA making fat more solid and stable at room 
temperature, but have been positively associated with the development of cardiovascular 
disease (Willet, 1998). 
The replacement of cis oriented unsaturated fatty acids with TFA has been linked 
to increased levels of LDL and decreased levels of HDL (Ascherio, Katan, Zock, 
Stampfer & Willet, 1999). It has been proposed that TFA has a negative impact on the 
LDL/HDL ratio is approximately twice as much as SFA; an increase of 2% TFA 
consumption may boost the ratio of LDL/HDL by 0.1 (Ascherio et al., 1999). A 1-unit 
increase in this ratio is associated with a 53% increase in the risk of cardiovascular 
disease (Stampfer, Sacks, Salvini, Willet & Henneckens, 1991), so the average 
consumption of 2% of calories derived from TFA could be a predictor of a high number 
of deaths from this disease (Ascherio et al., 1999). 
Dietary TFAs also increases serum triacylglycerols, LDL and liprotein levels 
while decreasing HDL (Hu et al., 2001; Sundram, Ismal, Hays, Jeyamalar & 
Pathmanatan, 1997). Meanwhile, Kyung and Campos (2003) have suggested that the 
effect of the intake of TFA on cardiovascular disease risk may be mediated by the effect 
of these fatty acids on LDL size. They found a significant correlation between increased 
intake of TFA and increased LDL size. The large LDL has high affinity for arterial 
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proteinglycans (Manning et al., 1994). Cell cholesterol particles are released to the 
connective tissue of the arterial wall (Rudel, Parko, Hedrick, Thomas & Williford, 1998). 
Increased TFA may increase the risk of thrombosis, as these are capable of 
adversely affecting metabolism and the balance of prostanoids, in competing for the 
enzyme Δ6 desaturase with linoleic and α-linolenic acid (Hu & Willett, 2001) . Likewise, 
it is suggested that the high uptake of TFA promotes insulin resistance in humans 
(Lovejoy, 1999). Research on TFA mechanisms reveals inconsistencies, however results 
from animal studies suggest that post-insulin receptor activation of insulin-stimulated 
serine/threonine protein kinase is impaired in muscle tissue from monkeys fed a high-
TFA diet (Kavanagh et al., 2007). 
The strongest evidence of the association between TFA consumption and 
cardiovascular risk, comes from four prospective studies: the Health Professionals 
Follow-up Study, the Alpha-Tocopherol and Beta-Carotene Cancer Prevention Study, 
Nurses’ Health Study and the Zutphen Aging Study. In these, the relative risk of 
cardiovascular disease associated with an absolute increase of 2% of energy from TFA, 
ranged from 1.28 (Oomen et al., 2001b) to 1.93 (Hu et al., 1999). 
In the Nurses’ Health Study, replacing 5% of energy from PUFAs with SFA was 
associated with reduced risk of cardiovascular disease of 42%. However, replacing 2% of 
the energy derived from TFA with PUFA was associated with a reduction of 53% (Hu et 
al., 1999). In this study, each increase of 2% of total calories as TFA was associated with 
a 39% increase in the risk of Type 2 Diabetes Mellitus. 
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In Costa Ricans, a positive association between TFA 18:2 in adipose tissue and 
risk of nonfatal myocardial infarction has been shown. In addition, a positive association 
of 16:1 between trans isomer levels and risk of nonfatal myocardial infarctions was 
found (Baylin et al., 2003). 
Baylin and colleagues (2003) also suggested that the 18:2 trans isomer may be 
more atherogenic than the 18:1 trans, although the first one is found more abundantly in 
the diet and adipose tissue. Lemaitre and colleagues (2002) have also reported a strong 
positive association between levels of 18:2 trans isomer in the membrane of red blood 
cells and risk of acute myocardial infarction. 
In addition, clinical trials have shown that the trans 18:1 isomer adversely affect 
the lipoprotein profile (Hu et al., 2001) and have recently reported that patients with 
cardiovascular disease have a higher concentration of this isomer in the subcutaneous fat 
tissue (Dlouhy et al., 2003). However, epidemiological studies in Costa Rica (Baylin et 
al., 2003) and elsewhere (Aro et al., 1995) have found no association between levels of 
18:1 trans isomer in adipose tissue and risk of myocardial infarction. 
In Costa Rican households, palm butter, margarine, dairy products and 
confectionery were the main sources of SFA in the diet of adolescents. Partially 
hydrogenated soybean oil was the main source of TFA, providing 34% of the total, while 
about 35% came from natural sources such as meat and dairy products. The rest was 
contributed by TFA palm butter, margarine, baked goods and others (Monge-Rojas, 
Campos & Fernández, 2005). 
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Compared to TFA of industrial origin, the effect of TFA of ruminant origin on 
cardiovascular disease risk is less clear. Experimental studies suggest that the latter may 
have an adverse effect on the lipid profile when consumed in amounts similar to those of 
industrial origin TFA (Mozzafarian & Willet, 2008). In contrast, epidemiological studies 
have found positive associations between TFA of ruminant origin and cardiovascular 
disease which is probably due to the fact that the levels of natural TFA consumption are 
relatively low. Additionally, there are differences between the natural and industrial 
isomers (Mozafarian, 2008). 
 
2.3 Dietary Guidelines and Fat Intake  
Despite the lack of evidence that diets high in fat promote cardiovascular disease, 
most dietary recommendations have aimed at reducing total fat rather than fat quality 
(Erkkila, de Mello, Riseus & Laaksonen, 2008). More recent recommendations, including 
the Dietary Guidelines for Americans 2010 include within its key recommendation the 
reduction of SFA to less than 10% of total energy intake, replacing them with MUFA and 
PUFA. In addition, TFA intake is recommended to be as low as possible, especially if the 
TFA comes from synthetic sources, to use oils to replace solid fats, and to increase 
consumption of low fat dairy products and fish (United States Department of Agriculture 
& United Stated Department of Health and Human Services, 2010). 
The Third Report of the National Cholesterol Education Program, Expert Panel on 
Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult 
Treatment Panel III) recommend the Therapeutic Lifestyle Changes Diet which includes 
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weight loss and physical activity and dietary modifications addressing both fat intake 
quantity and quality (National Institute of Health; National Heart, Lung and Blood 
Institute, 2002). Recommendations include: 
 A total fat intake of 25-35% total energy intake 
 PUFA up to 10% of total energy intake 
 MUFA up to 20% of total energy intake 
 SFA less than 7% of total energy intake 
These guidelines do not include specific recommendations for TFA, establishing 
they have a LDL increasing effect and should be kept at low intake. N-3 PUFA are 
included as an optional recommendation; however, fish intake is encouraged. Detection, 
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel 
IV) guidelines are currently under review and are expected to be released in 2012 
(Grundy et al., 2011).  
The dietary guidelines for Costa Rica suggest that only 25% of the total energy 
should come from fat (Ministerio de Salud, 1997), however the recommendations of the 
National Academy of Sciences and the Food and Nutrition Board (2005), and the Institute 
of Nutrition of Central America and Panama (1994) established as appropriate a range of 
25 to 30%. Recent studies indicate that most Costa Ricans usually have a fat intake less 
than or equal to 30%, which is supported by the results of nutrition surveys, revealing 
that only 35% in 1996 and 29% in 2001 of Costa Rican households exceeded the 
recommended fat intake (Ulate, 2006). 
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As a strategy to promote cardiovascular health in childhood and adolescence, and 
to prevent the development of cardiovascular disease in adulthood, the Committee on 
Atherosclerosis, Hypertension and Obesity in Youth of the American Heart Association 
(Williams et al., 2002) has emphasized the need to establish a diet low in saturated fat at 
an early age. The recommendations made by the committee included: 
 The total fat should provide no more than 30% or less than 20% of energy 
intake. 
 The SFA should provide less than 10% of energy intake. 
 PUFA should provide up to 10% of energy intake.  
 MUFA should provide 10-15% of energy intake. 
There are no officially recognized recommendations for the intake of specific 
fatty acids. The Working Group on the Recommended Dietary Intakes (RDIs) for 
Essentiality of Fatty Acids, Omega-6 and Omega-3 has proposed recommendations for 
adults. The suggested adequate intake of linoleic acid is 2 % of total energy consumption 
and an upper limit of 3% (Simopoulos, 1999). Additionally, they suggested an adequate 
intake of α-linolenic acid corresponding to 1% of daily energy intake. 
 
2.4 Fatty Acids, Chronic Disease and Cognitive Health 
In order to understand the mechanisms by which fatty acids affect the risk of 
cognitive health decline in older adults, it is imperative to understand the 
pathophysiology of atherosclerosis. Many diseases are capable of producing circulation 
disorders in the coronary vessels and in cerebral and peripheral arteries. The most 
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common of these is atherosclerosis. This is a multifactorial disease that develops 
chronically before becoming clinically symptomatic. The consequences of this disease 
are coronary disease, stroke and occlusive disease of the peripheral arteries (Stary et al., 
1995). 
Various theories have been proposed to explain the pathogenesis of 
atherosclerosis, which include the theory of response to injury (Ross, 1993), the theory of 
modified lipoproteins (Steinberg & Witztum, 1990), the theory of retention of LDL 
(Williams & Tabas, 1995) and the immune hypothesis (Wick et al., 1997). A combination 
of these theories reveals four factors involved in the pathogenesis: the vascular 
endothelium, LDL, macrophages and smooth muscle cells. They participate in an 
excessive inflammatory fibro-proliferative endothelium and smooth muscle arterial wall 
injury (Moreno & Mitjavila, 2003). This results in a hardening and narrowing of the 
arterial intima, which may partially or completely block blood flow, causing, depending 
on the affected area, heart attack, gangrene, kidney failure, and other disease states 
(Moreno & Mitjavila, 2003). 
These four hypotheses refer to an alteration in lipid profile as the main trigger of 
atherosclerotic plaque development. This plaque evolved chronically and silently, 
narrowing the arteries and leading to the development of vascular disease. Currently, 
scientific evidence has changed this view and notes that the influence of fatty acids in the 
development of chronic disease beyond the hypercholesterolemic effect. The fatty acid 
intake may affect thrombotic tendencies, heart rate, endothelial function, systemic 
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inflammation, insulin sensitivity and oxidative stress (Hu & Willett, 2001); all of which 
have been linked to longevity and cognitive function.  
There is a strong relationship between increasing age and high blood pressure. 
Normal aging produces an increase in systolic blood pressure due to decreased artery 
elasticity because of the thinning and fragmentation of vascular elastin and the collagen 
deposition (Copstead & Banasik, 2006; Rosendorff et al., 2007).  Until about 50 years of 
age, both systolic and diastolic blood pressure rise. After this, systolic blood pressure 
continues to rise; diastolic blood pressure tends to fall (Vasan et al., 2002). There is also 
epidemiological data that suggests an inversely proportional relationship between age of 
hypertension diagnosis and cardiovascular risk (National Research Council, 2000). 
 
2.4.1 Dietary Fatty Acids and Cognitive Health 
The causes of cognitive impairment are unknown. There are some studies on the 
role of the diet in cognitive decline in older adults (Vizuete, Robles, Rodriguez-
Rodriguez, Lopez-Sobaler & Ortega, 2010). Recent studies have suggested that dietary 
fatty acids may play a role in the development of cognitive decline associated with aging 
or dementia (Solfrizzi et al., 2005; van de Rest et al., 2009). 
One of the first studies was a population-based study conducted in France by 
Pradignac et al. The association among macronutrient intake and cognitive function was 
studied in 226 men and 215 women, aged 65 or more, free living and in good health. A 
positive relationship between fatty acid intake and the Mini Mental State Examination 
(MMSE) was found in women. In men, alcohol and PUFA intake was associated with an 
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improvement in functional and cognitive parameters. PUFA intake was also related to 
mobility in men. However, this study had a low response rate and these findings may be 
explained as indicators of better health status (Pradignac, Schlienger, Velten, & Mejean, 
1995). 
A similar study from Spain assessed the association between dietary intake and 
global cognitive functions using the MMSE and the Pfeiffer’s Mental State Questionnaire 
(PMSQ) in 260 free living mentally healthy older subjects. Subjects with adequate scores 
in the MMSE (>28 pts) had lower intake of SFA, MUFA and cholesterol (Ortega et al., 
1997). This study included macro and micro nutrients assessment, but did not include 
TFA intake.  
The Italian Longitudinal Study on Aging examined the relationship between 
macronutrients and cognitive impairment in a population-based sample of 278 subjects 
aged 65 to 84. MMES, selective attention (Digit Cancellation Test) and episodic memory 
(Babcock Story Recall Test) were used to assess cognitive status, while a semi-
quantitative food frequency questionnaire was used to evaluate macronutrient energy 
intakes. Cross-sectional results pointed toward an inverse relationship between MUFA, 
PUFA and cognitive decline (Solfrizzi et al., 2006). In this same study, a significant 
inverse association between MUFA intakes and selective attention was highlighted 
(Solfrizzi et al., 1999). 
Contrasting results were found by van de Rest et al (2008) in a similar study 
conducted in the United States. This study used a battery of tests including MMSE, 
memory tests, language test and perceptual speed and attention in 1025 elder men. Cross-
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sectional analysis found no association between fatty fish or PUFA (van de Rest et al., 
2008).  
Conflicting results were also found in studies of the association between plasma 
concentration of omega-3 PUFA and prevalence and incidence of cognitive impairment 
and dementia. Data from the Canadian Study of Health and Aging found no significant 
difference in omega-3 PUFA plasma concentrations between controls and both prevalent 
cases of cognitive impairment and dementia (Laurin, Verreault, Linsay, Dewailly & 
Holub, 2003). This is consistent with a population-based Italian study of 191 elders 
where no association was found between plasma phospholipid fatty acids and results 
from the MMSE (Manzato et al., 2003).  
Results from Conquer et al (2000), point in the opposite direction, suggesting that 
low levels of n-3 fatty acids in the plasma may be a risk factor for cognitive impairment, 
Alzheimer’s disease and/or dementia. However, statistical analyses from this study do not 
consider confounding factors such as age and educational level. Another limitation is that 
no dietary intakes or histories were done; therefore, it is unclear if the subjects presently 
consume, or consumed in the past, diets that were lower in PUFAs.  
Older adults with mild to severe cognitive impairment or any form of dementia 
may alter their diet as a result of their disease. In addition, dietary intakes can be altered 
by cognitive decline and impairment. Longitudinal studies can provide data to identify 
these observations.  
A three-year long prospective study examined the effects of dietary fatty acids on 
cognitive decline in 482 women. Dietary intake was assessed with Food Frequency 
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Questionnaire (FFQ) while cognitive status was evaluated with various tests including 
Consortium to Establish a Registry for Alzheimer’s disease (CERAD) word list learning, 
constructions and word fluency tests. Results showed no association between cognitive 
decline and intake of saturated fat, trans fat or dietary cholesterol intake. MUFA intake 
was associated with lower cognitive decline, particularly in the visual and memory 
domains (Naqvi et al., 2011). 
The Chicago Health and Aging Project followed 3718 subjects over 65 years old 
for six years. Dietary intake was evaluated with a 139-item FFQ. Cognitive change was 
measured at 3 and 6 years follow-ups with the East Boston Memory Test (EBT) of 
immediate and delayed recall and the MMSE and the Symbol Digit Modalities test for 
perceptual-motor speed (SDMT). Results suggest that a diet high in saturated and trans 
fats may be associated with cognitive decline in older adults (Morris, Evans, Tangney, 
Bienias & Wilson, 2004). Dietary fish intake was inversely associated with cognitive 
decline, while there were no consistent associations with n-3 PUFAS (Morris et al., 
2005). 
At the moment, the longest longitudinal study of the relationship between 
cognitive health and diet, called the Cardiovascular Risk Factors, Aging and Dementia 
(CAIDE) was conducted in Finland.  A population of 1449 people aged 65 to 80 years 
was followed for a total average of 21 years. A FFQ was used for dietary assessment. To 
determine the presence or absence of mild cognitive impairment, evaluations of cognitive 
and executive global functions, memory, and psychomotor skills were conducted. 
Abundant saturated fat at midlife was associated with poorer global cognitive function 
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and prospective memory after adjusting for confounders. In contrast, high intake of 
PUFA was associated with better semantic memory. Furthermore, frequent fish 
consumption was associated with better global cognitive function and semantic memory. 
Further, higher PUFA–SFA ratio was associated with better psychomotor speed and 
executive function (Eskelinen et al., 2008).  
 
2.5  Dietary Patterns and Cognitive Decline 
The traditional Mediterranean diet pattern is characterized by an abundance of 
plant foods (cereals, bread, fruits, nuts, potatoes); non-processed locally grown foods; 
locally grown fresh fruit as dessert; sweets eaten a few times a week; olive oil as the main 
source of fats; daily consumption of dairy products, low to moderate amounts of fish and 
poultry; low consumption of red meats, up to four eggs per week, and low to moderate 
consumption of red wine, usually with meals (Willet et al., 1995). This dietary pattern has 
been associated with a reduced risk of total mortality, cardiovascular diseases and cancer 
(de Logeril & Salen, 2006; Sofi, Cesari, Abbate, Gensini & Casini, 2008; Willet et al., 
1995). The Mediterranean diet has also been associated protection against cognitive 
decline in older adults, because it combines foods and nutrients that may have potentially 
protective effects against cognitive dysfunction: fish, MUFA, antioxidants, folates, 
cobalamine (vitamin B12) and red wine (Feart et al., 2009).  
A number of studies have looked into the role that specific foods and nutrients of 
this diet may have on the protective role against dementia of cognitive decline. These, 
studies on isolated nutrients or food have conflicted results (Feart, Samieri & Barberger-
 30 
Gateau, 2010), perhaps because the analyses of single nutrients or foods ignore important 
interactions among components. People do not eat nutrients or just one type of food; they 
have dietary patterns that are better suited to the dietary patterns analysis approach. 
Scarmeas et al., (2009) studies the association between the Mediterranean diet and 
Mild Cognitive Impairment (MCI), which identifies people who are in the transition 
between normal aging and dementia or Alzheimer’s disease. Results from this 
longitudinal multiethnic community study in New York (n=1393) suggest an association 
between the Mediterranean diet and reduced risk of developing MCI, and a reduced risk 
of MCI conversion to Alzheimer’s disease (Scarmeas et al., 2009). In this study sample, 
the association of a subsample of 262 of incident cases of Alzheimer’s disease was also 
investigated. Higher adherence to the Mediterranean diet was found to be associated with 
a reduction of Alzheimer’s disease risk (Scarmeas, Stern, Tang, Mayeux & Luchsinger, 
2006).  
A prospective cohort study of 1410 adults over 65 years old conducted in 
Bordeaux, France, evaluated adherence to the Mediterranean diet while assessing 
cognitive health with four neuropsychological tests, including the MMSE (Feart et al., 
2009). Results showed that a higher adherence to this type of diet was positively 
associated with fewer MMSE errors; however, this was not consistent with the cognitive 
tests (Feart et al., 2009).  
Nurk et al., 2007 examined fish and seafood consumption and cognitive 
performance in the Hordaland Health Study in Norway. This study has a sample of 2,031 
subjects ages 70 to 74 and used six different cognitive tests, including the MMSE. There 
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was a positive dose-dependent association between fatty fish intake and cognition (Nurk 
et al., 2007). 
The Zutphen Elderly Study (The Netherlands) followed 210 subjects ages 70-89 
during for five years. Dietary information was collected using the cross-check dietary 
history method and MMSE was used for cognitive assessment. Fish consumption was 
associated with decreased cognitive decline. Furthermore, combined intake on EPA and 
DHA seemed to have a dose-dependent relation with reduced cognitive decline (van 
Gelder et al., 2007). 
Since the evidence remains inconclusive, the Mediterranean diet pattern and fish 
intake, does not fully explain the better health of persons with this kind of dietary pattern, 
although it may contribute to it. Moreover, this diet may indirectly represent an indicator 
of a complex set of favorable lifestyle factors that altogether may contribute to better 
health outcomes.  
 
2.6 Supplement Use and Cognitive Health 
Nutrient supplementation of both micronutrients and macronutrients are widely 
used to improve diet quality and contribute to the maintenance of good health across the 
life span. Assessments of the association of supplement use and cognitive health has been 
limited by the finding that those who seem to have healthier lifestyles are also more 
likely to use supplements (Conner, Kirk, Cade & Barrett, 2001). 
In a nested case-control study, fish oil users were matched with nonusers, and 
cognitive function was related to erythrocyte n-3 fatty acid composition. Results 
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suggested that food supplement use and erythrocyte n-3 content are associated with better 
cognitive aging (Whalley et al., 2008) 
A comprehensive literature revealed only two randomized clinical trials resulting 
in publication on PUFA supplementation on elderly subjects. The first study was 
conducted by Terano et al 1999 in Japan. The Older People and n-3 Long-Chain 
Polyunsaturated Fatty Acids Study (OPALS) study conducted in the United Kingdom 
recruited 867 participants ages 70–79 years; at baseline, all were free of dementia and 
diabetes, had a minimum of 25 out of 30 in the MMSE score and did not report daily fish 
oil supplement consumption. Subjects were randomly assigned into a double-blind 
controlled trial of daily capsules providing EPA, DHA or olive oil.  A standardized 
battery of cognitive tests was used, including but not limited to subjective memory 
assessment, tests of prospective memory, story recall (immediate and delayed), verbal 
fluency, location memory (immediate and delayed) and symbol-letter substitution. After 
24 months, results supported the theory that high levels of fish consumption, especially 
fatty fish, were associated with better cognitive function in later life (Dangour et al., 
2009). 
 
 
 
 
 
 
 33 
References 
 
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willet, W. C., 
& Ma, J. (2002). Blood Levels of long – chain n-3 fatty acids and the risks of 
sudden death. The New England Journal of Medicine, 345, 1113-1118. 
 
Aro, A., Kardinaal, A. F., Salminen, I., Kark, J. D., Rimersma, R. A., Delgado-
Rodríguez, M., Gomez-Aracena, J., Hutturnen, J. K., Koklmeir, L., Martin, B. C., 
Martin-Moreno, J. H., Mazeav, V. P., Ringstad, J., Thamm, M., van`t Vee, P., & 
Kok, F. J. (1995). Adipose tissue isomeric trans fatty acids and risks of myocardial 
infarction in nine countries: The EUREMIC study. Lancet, 345, 273-778. 
 
Ascherio, A. (2002). Epidemiologic studies on dietary fats and coronary heart disease. 
American Journal of Medicine, 113, 95-125. 
 
Ascherio, A., Katan, M. B., Zock, P. L., Stampfer, M. J., & Willet, W. C. (1999). Trans 
fatty acids and coronary heart disease. The New England Journal of Medicine, 
340(25), 1994-1998. 
 
Ascherio, A., Rimm, E.B., Giovannucci, E.L., Spiegelman, D., Stampfer, M., & Willet, 
W.C. (1996). Dietary fat and risk of coronary heart disease in men: Cohort follows 
up study in the United States, BMJ, 313, 84-90. 
 
Baylin, A., Kabagambe, E., Ascherio, A., Spiegelman, D. & Campos, H. (2003). High 
18:2 trans-fatty acids in adipose tissue are associated with increased risks of 
nonfatal acute myocardial infarction in Costa Rica adults. Journal of Nutrition, 133, 
1186-1191. 
 
Brenes-Camacho, G. & and Rosero-Bixby, L. (2008). Metabolic control in a nationally 
representative diabetic elderly sample in Costa Rica: Patients at community health 
center vs. patients at other health care settings. BMC International Health and 
Human Rights, 8(5), 1-13. 
 
Brenes-Camacho, G. & Rosero-Bixby, L. (2009). Differentials by Socioeconomic Status 
and Institutional Characteristics in Preventive Service Utilization by Older Persons 
in Costa Rica. Journal of Aging and Health, 21, 730-758 
 
Conner, M., Kirk, S. F. L., Cade, J. E. & Barrett, J. H. (2001). Why do women use 
dietary supplements? The use of the theory of planned behaviour to explore beliefs 
about their use. Social Science and Medicine, 52, 621–633. 
 
 34 
Connor, W. (2002). α -Linolenic acid in heath and disease. American Journal of Clinical 
Nutrition, 69, 827-828. 
 
Conquer, J.A., Tierney, M.C., Zecevic, J., Bettger, W.J., & Fisher, R.H. (2000). Fatty 
Acid Analysis of Blood Plasma of Patients with Alzheimer’s disease, Other Types 
of Dementia, and Cognitive Impairment, Lipids, 35, 1305–1312. 
 
Copstead, L. C., & Banasik, J. L. (2006). Pathophysiology (4rd Ed). Elsevier: Missouri. 
 
Dangour, A.D., Allen, E., Elbourne, D., Fletcher, A., Richards, M., & Uauy, R. (2009). 
Fish consumption and cognitive function among older people in the UK: Baseline 
data from the OPAL study, Journal of Nutrition and Healthy Aging, 13, 198–202. 
 
De Bertodano, I. (2003). The Costa Rican health system: Low cost, high value. Bulletin 
of the World Health Organization, 81, 626-627. 
 
Djoussé, L., Pankow, J. S., Eckfeldt, J. H., Aaron, R. F., Hopkins, P. N., Province, M. A., 
Hong, Y., & Ellison, R. C. (2004). Relationship between dietary linolenic acid and 
coronary artery disease in the National Heart, Lung, and Blood Institute Family 
Heart Study. American Journal of Clinical Nutrition, 14, 612-619. 
 
Dlouhy, P., Tvrzická, E., Sta ková, B., Vecka. M., ák, A., Straka, ., Fanta, J., Pachl, J., 
Kubisová, D., Rambousková, J., Bílková, D., & And l, M. (2003). Higher Content 
of 18:1 Trans Fatty Acids in Subcutaneous Fat of Persons with Coronarographically 
Documented Atherosclerosis of the Coronary Arteries. Annals of Nutrition and 
Metabolism, 47, 302-305. 
 
Dolecek, T.A. (1992). Epidemiological evidence of relationship between dietary 
polyunsaturated fatty acids and mortality in the Multiple Risks Factor Intervention 
Trial. Proceedings of Society for Experimental Biology and Medicine, 200, 177-
182. 
 
Erkkila, A., de Mello, V. D., Riseus, U., & Laaksonen, D. E. (2008). Dietary fatty acids 
and cardiovascular disease: An epidemiological approach. Progress in Lipid 
Research, 47, 172-187. 
 
Eskelinen, M.H., Ngandu, T., Helkala, E.L., Tuomilehto, J., Nissinen, A., Soininen, H., & 
Kivipelto, M. (2008). Fat intake at midlife and cognitive impairment later in life: A 
population-based CAIDE study, International Journal of Geriatric Psychiatry, 23, 
741–747. 
 
Feart, C., Samieri, C., & Barberger-Gateau, P. (2010). Diet and Alzheimer’s disease: 
New evidence from epidemiological studies. Recent Advances on Nutrition and the 
Prevention of Alzheimer’s Disease, 37(2), 19-40       
 35 
 
Feart, C., Samieri, C., Rondeau, V., Amieva, H., Portet, F., Dartigues, J. F., Scarmeas, N. 
& Barberger-Gateau, P. (2009). Adherence to a Mediterranean Diet, Cognitive 
Decline, Risk of Dementia. Journal of the American Medicine Academy, 302(6), 
638-648.  
 
Gersten, O., Dow, W.H. & Rosero-Bixby, L. (2010). Stressors Over the Life Course and 
Neuroendocrine System Dysregulation in Costa Rica. Journal of Aging and Health, 
22(6), 1-24. 
 
Grundy, S M., Bilheimer, C. D., Blackburn, H., Brown, W. V., Kwiterovich, P. O., 
Mattson, F., Schonfeld, G., & Weodman, W. H. (1982). Rationale of the diet- heart 
statement of American Heart Association. Report of Nutrition Committee. 
Circulation, 65, 837-854 
 
Guallar, E., Aro, A., Jiménez, J., Martín-Moreno, J. M., Salminen, I., van`t Verr, P., 
Kardinal, A. F. M., Gómez-Aracena, J., Martin, B. C., Kohlmeier, L., Kark, J. D., 
Mazaev, V. P., Ringstad, J., Guillén, J., Riemersma, R. A., Huttunen, J. K., Thamm, 
M., & Kok, F. J. (1999). Omega 3 fatty acids in adipose tissue and risks of 
myocardial infarction. The EUREMIC Study. Arterosclerosis, Thrombosis and 
Vascular Biology, 19, 1111-1118. 
 
Gurr, M.I., Harwood, J.L., & Frayn, K. (2002). Lipid biochemistry. 5ed. London: 
Blackwells.  
 
Hegsted, D. M., McGandy, R. B., Myers, L. M., & Stare, F. J. (1965). Quantitative 
effects of dietary fat on serum cholesterol in man. American Journal of Clinical 
Nutrition, 17, 281-295. 
 
Hu, F. B., Manson, J.E., & Willet, W.C. (2001). Types of dietary fat and risks of 
coronary heart disease: A critical review. Journal of American College of Nutrition, 
20, 5-19. 
 
Hu, F. B., Stamfler, M. J., Manson, J. E., Rimm. E., Colditz, G. A., Rosner, B. A., 
Hennekens, C. H., & Willet, W. C. (1999). Dietary proteins and risks of coronary 
heart disease in women. American Journal of Clinical Nutrition, 70, 221-227. 
 
Hu, F.B., & Willet, W.C. (2001). Diet and coronary heart disease: Findings from the 
nurses'health study and health professionals' follow-up study. Journal of Nutrition 
Health and Aging, 3, 132-138. 
 
Instituto de Nutrición de Centroamérica y Panamá [INCAP] (1994). Recomendaciones 
Dietéticas Diarias del INCAP. Guatemala, Guatemala: INCAP. 
 
 36 
Jones, P. J. H., & Kubows, S. (1998). Lipidos, esteroles y sus metabolitos.  En: Shils, M. 
E., Olson, J. A., Shike, M., & Ross, A. C. (Eds.). Nutrición en Salud y Enfermedad, 
(pp.77-86). México, D.F.: McGraw-Hill. 
 
Kavanagh, K., Jones, K. L., Sawyer, J., Kelley, K., Carr, J., Wagner, J. D. & Rudel, L. L. 
(2007). Trans Fat Diet Induces Abdominal Obesity and Changes in Insulin 
Sensitivity in Monkeys. Obesity, 15, 1675-1684.  
 
Keys, A., Anderson, J., & Grande, F. (1965). Serum cholesterol response to changes in 
the diet. IV. Particular fatty acids in the diet. Metabolism, 14, 776-787. 
 
Kunitz, S. (2007). Sex, race and social role – history of the social determinants of health. 
International Journal of Epidemiology, 36, 3-10.  
 
Kyung, M. K., & Campos, H. (2003). Intake of trans fatty acids and low-density 
lipoprotein size in a Costa Rican population. Metabolism, 52, 693-698. 
 
Laurin, D., Verreault, R., Lindsay, J., Dewailly, E., & Holub, B.J. (2003). Omega-3 fatty 
acids and risk of cognitive impairment and dementia, Journal of Alzheimer's 
Disease, 5, 315-322. 
 
Leimatre, R. N., King, I. B., Raghunathan, T. E., Pearce, R. M., Weinmann, S., Knopp, 
R. H., Copass, M. K., Cobb, L. A., & Siscovick, D. S. (2002) Cell membrane trans-
fatty acids and the risks of primary cardiac arrest. Circulation, 105, 697-701. 
 
Lovejoy, J. C. (1999). Dietary fatty acids and insulin resistance. Current Atherosclerosis 
Reports, 1, 215-220. 
 
Manning, J. M., Gebre, A. K., Edwards, I. J., Wagner, W. D., Rudel, L. L., & Parks, J. S. 
(1994). Dietary polyunsaturated fat decreases interaction between low density 
lipoproteins and arterial proteoglycans. Lipids, 29, 635-641. 
 
Manzato, E., Rosellidella Rovere, G., Zambon, S., Romanato, G., Corti, M.C., Sartori, L. 
Baggio, G., & Crepaldi, G. (2003). Cognitive functions are not affected by dietary 
fatty acids in elderly in the Pro V.A study population, Aging, 15, 83-86.  
 
McEwen, B. S & Stellar, E (1993). Stress and the individual mechanisms leading to 
disease. Archive of Internal Medicine, 153(18), 2093-2101. 
 
Mendez-Chacon, E., Santamaria-Ulloa, C. & Rosero-Bixby, L. (2008). Factors associated 
with hypertension prevalence, unawareness and treatment among Costa Rican 
elderly. BMC Publich Health, 8, 275. 
 
 37 
Ministerio de Salud [MS]. (1997). Guías alimentarias para la educación nutricional en 
Costa Rica. San José, Costa Rica: Ministerio de Salud.  
 
Monge-Rojas, R., Campos, H. & Fernández, X. (2005). Saturated and cis-and trans – 
unsaturated fatty acid intake in rural and urban Costa Rican adolescents. Journal of 
American College of Nutrition, 24, 286-293. 
 
Moreno, J. J. & Mitjavila, M. T. (2003).  The degree of unsaturation of dietary fatty acids 
and the development of atherosclerosis (review). The Journal of Nutritional 
Biochemistry, 14, 182-195. 
 
Morris, M.C., Evans, D.A, Bienias, J.L., Tangney, C.C., Bennet, D.A., & Wilson, R.S. 
(2004). Dietary fat intake and 6-year cognitive change in an older bi-racial 
community. Neurology, 62, 1573-1579. 
 
Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L., & Wilson, R.S. (2005). Fish 
consumption and cognitive decline with age in a large community study. Archives 
of Neurology, 62, 1849-1853. 
 
Mozaffarian, D. (2008). Commentary: Ruminant trans fatty acids and coronary heart 
disease—cause for concern? International Journal of Epidemiology, 37, 182–184. 
 
Mozaffarian, D., & Willet, W. C. (2008).  Ruminant or industrial sources of trans fatty 
acids: public health issue of food label skirmish? American Journal of Clinical 
Nutrition, 87, 515-516. 
 
Naqvi, A. Z., Harty, B.,  MS, Mukamal, K.J., Stoddard, A. M., Vitolins, M., & Dunn, J. 
E. (2011). Monounsaturated, Trans, and Saturated Fatty Acids and Cognitive 
Decline in Women, Journal of the American Geriatrics Society, 59(5), 837-843 
 
National Academy of Science [NAS] & Food and Nutrition Board [FNB] (2005). Dietary 
Reference Intake for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, 
protein and amino acids. Washington, D.C., USA: The National Academies Press. 
 
National Institute of Health & National Heart, Lung and Blood Institute (2002). Third 
Report of the National Cholesterol Education Program (NCEP) Expert Panel on 
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult 
Treatment Panel III) Final Report. NIH Publication No. 02-5215. 
 
National Research Council (2000). The aging mind: Opportunities in cognitive research. 
Washington, D. C.: National Academy Press.  
 
 
 
 38 
Nurk, E., Drevon, C.A., Refsum, H., Solvoll, K., Vollset, S.E., Nygard, O.,Nygaard, H.A, 
Engedal, K., Tell, G.S., & Smith, A.D. (2007). Cognitive performance among the 
elderly and dietary fish intake: the Hordaland Health Study, American Journal of 
Clinical Nutrition, 86, 1470-1478. 
 
Oomen, C. M., Ocke, M. C., Feskens, E. J. M., Kok, F. J., & Kromhout, D. (2001a). α -
Linolenic acid intake in not beneficially associated with 10–y risks of coronary 
artery disease incidence: The Zutphen Elderly Study. American Journal of Clinical 
Nutrition, 74, 757-763. 
 
Oomen, C. M., Ocke, M. C., Feskens, J. M., van Erp-Barst, M. J., Kok, F. J., & 
Kromhout, D. (2001b). Association between trans fatty acids and 10-year risks of 
coronary heart disease in the Zutphen Elderly Study: A prospective population-
based study. Lancet, 357, 746-751. 
 
Ortega, R. M., Requejo, A.M., Andres, P., Lopez-Sobaler, A.M., Quintas, M.E., 
Redondo, M.R., Navia, B., & Rivas, T. (1997). Dietary Intake and Cogntive 
Function in a group of elderly people, American Journal of Clinical Nutrition, 66, 
803-809.  
 
Pedersen, J. I., Ringstand, J., Almendingen, K., Haugen, T. S., Stensvold, I., & Thelle, D. 
S. (2000). Adipose tissue fatty acid and risks of myocardial infarction: A case-
control study. European Journal of Clinical Nutrition, 54, 618-625. 
 
Pietinen, P., Ascherio, A., Korhonen, P., Hartman, A. M., Willet, W. C., Albanes, D., & 
Virtamo, J. (1997) Intake of fatty acids and risks of coronary heart disease in a 
cohort of Finnish men: The alpha-tocopherol, beta-carotene cancer prevention 
study. American Journal of Epidemiology, 145, 876-887. 
 
Pradignac, A., Schlienger, J. L., Velten, M., & Mejean, L. (1995). Relationships between 
macronutrient intake, handicaps and cognitive impairments in free living elderly 
people, Aging, 7, 67-74.  
 
Rehkopf, D. H., Dow, W. H. & Rosero-Bixby, L. (2009). Differences in the association 
of cardiovascular risk factors with education: a comparison of Costa Rica 
(CRELES) and the United States (NHANES). Journal of Epidemiology and 
Community Health, 64(9), 1-13.  
 
Renaud, S., & Lanzmann-Petithory, D. (2001). Coronary heart disease: Dietary links and 
pathogenesis. Public Health Nutrition, 4(2B), 459-474. 
 
Rosello-Araya, M., & Guzmán-Padilla, S. (2004). Evolución de la mortalidad por 
enfermedad isquémica del corazón e infarto agudo del miocardio en Costa Rica, 
1970–2001. Revista Panamericana de Salud Pública, 16(5), 295-301. 
 39 
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, G. J.,  Izzo, J. L., 
Kaplam, N. M., O’Connor, C. M., & Clive, P. T. (2007). Treatment of Hypertension 
in the Prevention and Management of Ischemic Heart Disease: A Scientific 
Statement From the American Heart Association Council for High Blood Pressure 
Research and the Councils on Clinical Cardiology and Epidemiology and 
Prevention. Circulation, 115, 2761-2788. 
 
Rosero-Bixby, L. & Dow, W. H. (2009). Surprising SES Gradients in Mortality, Health 
and Biomarkers in a Latin American Population of Adults. Journal of Gerontology: 
Social Sciences, 64B(1), 1-13. 
 
Rosero-Bixby, L. (1995). Adult Mortality Decline in Costa Rica. In V. M. Gomez (Ed). 
Actualidad Demográfica de Costa Rica. (pp. 3.1-3.25). San Jose, Costa Rica: Fondo 
de Poblaciones de las Naciones Unidad.  
 
Rosero-Bixby, L. (1996). The decline in adult mortality in Costa Rica. In J. Chackiel, L. 
Ruzicka, & I. Timaeus (Eds.), Adult mortality in Latin America (pp. 166-196). 
Oxford, UK : Clarendon Press 
 
Rosero-Bixby, L. (2004a). Spatial Access to health care in Costa Rica and its equity: a 
GIS-based study. Social Science and Medicine, 58, 1271-1284.  
 
Rosero-Bixby, L. (2004b). Evaluación del impacto de la reforma del sector salud en 
Costa Rica. Revista Panamericana de Salud Pública, 15(2), 94-103. 
 
Rosero-Bixby, L. (2008). The Exceptionally High Life Expectancy of Costa Rican 
Nonagenarians. Demography, 45(3), 673-691.  
 
Rosero-Bixby, L., Dow, W. H. & Lacle, A. (2005). Insurance and other socioeconomic 
determinants of elderly longevity in a Costa Rican Panel. Journal of Biosocial 
Sciences, 37, 705-720. 
 
Ross, R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. 
Nature, 362, 801-809. 
 
Rubio, A. (2002). Cardiovascular disease and fats: Friend or foe. Endocrinology and 
Nutrition, 49, 145-167. 
 
Rudel, L. L., Parko, J. S., Hedrick, C. C., Thomas, M. & Williford, K. (1998). 
Lipoproteins and cholesterol metabolism in diet – induced coronary artery 
atherosclerosis in primates. Role of cholesterol and fatty acids. Progress in Lipid 
Research, 37, 353-370. 
 
 40 
Sacks, F., & Katan, M. (2002). Randomized clinical trials on the effects of dietary fat and 
carbohydrate on plasma lipoproteins and cardiovascular disease. American Journal 
of Medicine, 113, 135-245. 
 
Salmeron, J., Hu, F.B., Manson, J. E., Stampfer, M. J., Colditz, G.A., Rimm, E. B., & 
Willet, W. C. (2001). Dietary fat intake and risk of type 2 diabetes in women. 
American Journal of Clinical Nutrition, 73, 1019-1026.  
 
Scarmeas, N., Stern, Y., Mayeux, R., Manly, J.J., Schupf, N. & Luchsinger, J. A. (2009). 
Mediterranean diet and mild cognitive impairment. Archives of Neurology, 66, 216-
25. 
 
Scarmeas, N., Stern, Y., Tang, M., Mayeux, R. & Luchsinger, J. A. (2006). 
Mediterranean Diet and Risk for Alzheimer’s disease. Annuals of Neurology, 59, 
912-921.  
 
 Seeman, T. E., Singer, B. H., Rowe, J. W., Horwitz, R. I. & McEwen, B. S. (1997). Price 
of adaptation-allostatic load and its health consequences: MacArthur studies of 
successful aging. Archives of Internal Medicine, 157, 2259-2268. 
 
Seeman, T., Merkin, S. M., Crimmins, E. M., Koretz, B., Charette, S., & Karlamangla, A. 
(2008). Education, income and ethnic differences in cumulative biological risk 
profiles in a national sample of US adults: NHANES III (1988-1994). Social 
Science & Medicine, 66(1), 72–87. 
 
Simopoulus, A. (1991). Omega-3 fatty acids in health and disease and in growth and 
development. American Journal of Clinical Nutrition, 54, 438-463. 
 
Simopoulus, A. (1999). Essential fatty acids in health and chronic disease. American 
Journal of Clinical Nutrition, 70(Suppl), 560-569. 
 
Sofi, F., Cesari, F., Abbate, R., Gensini, G. F. & Casini, A. (2008). Adherence to 
Mediterranean diet and health status: Meta-analysis. BMJ, 1337-1344. 
 
Solfrizzi, V., Colacicoo, A. M., D’Introno, A., Capurso, C., Torres, F., Rizzo, C., 
Capurso, C. & Panza, F. (2006). Dietary intake of unsaturated fatty acids and age-
related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on 
Aging. Neurobiology of Aging, 27, 1694–1704. 
 
Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Capurso, S., 
Gadaleta, A., Capurso, A. & Panza, F. (2005) Dietary fatty acids intakes: Possible 
role in cognitive decline and dementia. Experimental Gerontology, 40, 257-270.  
 
 41 
Solfrizzi, V., Panza, F., Torres, F. Mastroianni, F., Del Parigi, A., Venezia, A., & 
Capurso, A. (1999). High monounsaturated fatty acid intake protects against age 
related cognitive decline. Neurology, 52, 1563-1569.,  
 
Stampfer, M. J., Sacks, F. M., Salvini, S., Willet, W. C., & Hennekens, C. H. (1991). A 
prospective study of cholesterol, apolipoproteins, and the risks of myocardial 
infarction. The New England Journal of Medicine, 325, 373-381. 
 
Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J. R., Insull, W., Rosenfeld, M. E., 
Schaffer, S. A., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995). A 
definition of initial, fatty streak, and intermediate lesions of atherosclerosis.  A 
report from the Committee on Vascular Lesions of the Council on Artherosclerosis, 
American Heart Association. Circulation, 89, 2462-2478. 
 
Steenland, K., Henley, J. & Thun, M. (2002). All-cause and cause-specific death rates by 
education status for 2 million people in two American cancer cohorts, 1959-1996. 
American Journal of Epidemiology, 148, 958-966.  
 
Steinberg, D., & Witztum, J.L. (1990). Lipoproteins and atherosclerosis: current 
concepts.  Journal of American Medical Association, 264, 3047-3052. 
 
Sundram, K., Ismail, A., Hays, K. C., Jeyamalar, R. & Pathmanathan, R. (1997). Trans 
(Elaidic) fatty acids adversely affect the lipoprotein profile relative to specific 
saturated fatty acids in humans. Journal of Nutrition, 127, 514S–520S. 
 
Terano,T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., 
Yazawa, K., & Hirayama, T. (1999). Docosahexaenoic acid supplementation 
improves the moderately severe dementia from thrombotic cerebrovascular 
diseases, Lipids, 34(Suppl.), S345–S346. 
 
Ulate, E. (2006). Principales tendencias de la situación nutricional de la población de 
Costa Rica y su atención en el perido 1996-2006. En: Programa estado de la nación. 
(eds). Duodécimo informe Estado de la Nación en Desarrollo Humano Sostenible. 
San José: CONARE. 
 
United Nations (2009). Economic and Social Affair. Population Ageing and 
Development. Accessed on 10/10/2010 
http://www.un.org/esa/population/publications/ageing/ageing2009chart.pdf 
 
United States Department of Agriculture & United Stated Department of Health and 
Human Services (2010). Dietary Guidelines for Americans 2010. (7
th
 Edition). 
Government Printing Office: Washington , DC. 
 
 42 
van de Rest, O., Geleijnse, J.M., Kok, F.J., van Staveren, W.A., Dullemeijer, C., 
Olderikkert, M.G., Beekman, A.T., & de Groot, C.P. (2008). Effect of fish oil on 
cognitive performance in older subjects: a randomized, controlled trial, Neurology, 
71, 430–438. 
 
van Gelder, B.M., Tijhuis, M., Kalmijn, S., Kromhout, D. (2007). Fish consumption, n-3 
fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen 
Elderly Study, American Journal of Clinical Nutrition, 85, 1142–1147. 
 
Vasan, R. S., Beiser, A.,  Seshadri, S., Larson, M. G., Kannel, W. B.,  Agostino, R. B. & 
Levy, D. (2002).  Residual Lifetime Risk for Developing Hypertension in Middle-
aged Women and Men: The Framingham Heart Study. Journal of American 
Medical Association, 287, 1003-1010. 
 
Vizuete, A. A., Robles, F., Rodriguez-Rodriguez, E., Lopez-Sobaler, A. M. & Ortega, R. 
M. (2010). Association between food and nutrient intakes and cognitive capacity in 
a group of institutionalized elderly people. European Journal of Nutrition, 49, 293-
300.  
 
Whalley, L. J., Deary, I, J., Starr, J. M., Wahle, K. W., Rance, K. A., Bourne, V. J. &Fox, 
H. C. (2008). n–3 Fatty acid erythrocyte membrane content, APOE ε4, and 
cognitive variation: an observational follow-up study in late adulthood. American 
Journal of Clinical Nutrition, 87(2), 449-454. 
 
Wick, G., Romen, M., Amberger A., Metzler, B., Mayr, M., Falkensammer, M., & Xu, 
Q. B. (1997). Artherosclerosis, autoimmunity, and vascular – associated lymphoid 
tissue. The Journal of the Federation of American Societies for Experimental 
Biology, 11, 1199-207 
 
Willett, W. C. (1998). Nutritional epidemiology. 2nd Ed. New York: Oxford University 
Press. 
 
Willett, W.C., Sacks, F., Trichopoulou, A., Drescher, G., Ferro-Luzzi, A., Helsing, E. & 
Trichopoulous, D. (1995). Mediterranean diet pyramid: A cultural model for 
healthy eating. American Journal of Clinical Nutrition, 61, 1402S-1406S. 
 
Williams, C. L, Hayman, L. L., Daniels, S. R., Robinson, T. N., Steinber, J., Parindon, S., 
& Bazarre, T. (2002). Cardiovascular health in childhood.  A statement for health 
professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in 
the Young (AHOY) of the council on Cardiovascular disease in the Young, 
American Heart Association. Circulation, 106, 143-160. 
 
Williams, K. J., & Tabas, I. (1995). The response to retention hypothesis of early 
atherosclerosis.  Arteriosclerosis, Thrombosis and Vascular Biology, 15, 551-561.  
 43 
World Health Organization (2009). Global Health Observatory Costa Rica: Health 
Profile. http://www.who.int/gho/countries/cri.pdf 
 
World Health Organization (2010). Noncommunicable diseases country profiles. Geneva: 
WHO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
CHAPTER THREE 
MATERIALS AND METHODS 
 
3.1 Study design 
This is a cross-sectional secondary data analysis from the Costa Rican Longevity and 
Healthy Aging Study (CRELES, or Costa Rica Estudio de Longevidad y Envejecimiento 
Saludable) public use data files (Rosero-Bixby, Fernández, & Dow, 2005a). All terms 
and conditions from the Inter-University Consortium for Political and Social Research 
(ICPSR) for the use of this data base have been met (see Appendix A). CRELES is a 
nationally representative longitudinal survey of health and socioeconomic indicators of 
Costa Rican residents ages 60 and over in 2005. It was the first nationally representative 
survey to investigate older adult health levels in the country. 
The principal investigator is Luis Rosero-Bixby; co-principal investigators area Xinia 
Fernández (University of Costa Rica) and William H. Dow (University of California, 
Berkeley). The study design and data collection were conducted by the University of 
Costa Rica's Centro Centroamericano de Población (CCP) in collaboration with the 
Instituto de Investigaciones en Salud (INISA), with the support of the Wellcome Trust 
(grant 072406). Additional collaborating public entities include the Costa Rican Office of 
Social Security (CCSS) and the National Council of Senior Citizens (CONAPAM).  
This study was approved by the Ethical Science Committee of the University of Costa 
Rica in its March 17, 2004, session (reference: VI-763-CEC-23 -04), research project 
number 828-A2 -825 (see Appendix B). All of the databases of the study are anonymous 
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(i.e., names and identifiers have been removed) to avoid breeches in the privacy of the 
participants. For secondary data analysis, The Clemson University Office of Research 
Compliance determined that this thesis does not involve human subjects as defined in the 
federal regulations governing the protection of human subjects in research [45 CRF 
46.1029(f)] (see Appendix C). Therefore, it was not subject to the Institutional Review 
Board review.  
 
3.2 Sampling  
The sample was drawn from Costa Rican residents in the 2000 population census 
who were born in 1945 or before, with an over-sample of the oldest old (ages 95 and 
over), including an in-depth longitudinal survey in a subsample of 3,000 of these 
individuals. The inclusion criteria are residence in Costa Rica, regardless of nationality, 
and a birth date prior to 1946 (i.e., 60 years or older at the time of the first interview).  
A random selection was made from the database of the Census of Population of 
2000 (Insituto Nacional de Estadística y Censo, 2000). Sampling was stratified by 5-year 
age groups, varying from 1% of the population born from 1941 to 1945 up to 100% of the 
population born before 1905 (over 95 years old at the time of the first data collection 
round). A subsampling of 60 of the 102 health areas in Costa Rica covering 59% of the 
national territory, was selected (see Figure 1), According to the 2000 Census (INEC, 
2000) this subsample of nearly 5,000 people met the inclusion criteria, making it possible 
to locate and interview 2,827 individuals (n=1,329 men, n=1,498 women). The no-
answer rates can be categorized into several groups: 19% of people were deceased by 
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date of contact, 18% of people could not be located (mostly due to inaccurate addresses), 
2% had changed residence, and 4% declined to be interviewed. Among those who were 
interviewed, 95% gave a blood sample, 92% gave a urine sample. 
 
Figure 3.1 Map of the interviewed subjects from the selected Health Areas 
(Rosero-Bixby, Fernández & Dow, 2005b).  
  
3.2 Data Collection 
Baseline household interviews were conducted between November 2004 and 
September 2006, with two-year follow-up interviews. CRELES public use data files 
contain information on a broad range of topics, including self-reported physical health, 
psychological health, living conditions, health behaviors, healthcare utilization, social 
support, and socioeconomic status.  
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A field team of five interviewers, two phlebotomists, and a field supervisor collected 
the information and the blood and urine specimens using a continuous fieldwork design 
over a period of nearly 2 years. All data and specimens in the study were collected at the 
participants’ homes, usually during two visits, using personal digital assistants (PDAs), 
also known as palm computers, with software applications developed by CCP for this 
study. To ensure a good level of dependability, the PDA data collection was tested during 
the pilot study by registering answers in both paper and pencil and PDA (Hidalgo-
Cespedes, Rosero-Bixby, & Antich-Moreno, 2007). The PDA software did not allow 
registering inconsistent data, entering data outside of the range, and/or skipping the 
sequence of questions. Once the interview was completed, the data were ready for 
analysis, without the possibility of transcription errors (Hidalgo-Cespedes et al., 2007). 
During the first visit, participants provided informed consent and answered a 90-
minute long questionnaire. During the second visit, typically conducted early in the 
morning the day after the initial interview, urine samples, blood samples and 
anthropometric measures were collected by trained personnel. 
 
3.3.1 Diet.  
A semi-quantitative questionnaire based on Willet et al.’s (1985) questionnaire, 
was developed specifically for Costa Rican populations (Campos et al., 1991). This 
questionnaire asks for the average consumption during the previous year (prior to the day 
of the survey). The nine options to categorize consumption frequency range from ―never 
or less than once a month‖ to ―6 or more times a day.‖ Information about vitamins and 
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nutritional supplements as well as most frequently used type of fat or oil for cooking 
(shortening, margarine, etc.) at home was also requested. For each individual, the intake 
of energy and other nutrients was calculated by multiplying the frequency of 
consumption of each food by the nutritional content of the respective portion. Using 
stepwise regression, CRELES researchers reduced the original 147-item FFQ to an 
abbreviated version, identifying 27 tracer foods in addition to the type of oil used for 
cooking. This step was to done to gather information on the nutrients of greater interest as 
well as reduce the interview time (Rosero-Bixby et al., 2005b) 
 
3.3.2 Cognitive disability.  
Cognitive disability was assessed using a 15-item scale (Cronbach’s alpha = 0.72) 
adaptation of the Mini-Mental State Examination (MMSE) (Folstein, Folstein, & 
McHugh, 1975; Quiroga, Albala, & Klaasen, 2004; Rosero-Bixby & Dow, 2009). 
Participants who answered fewer than 75% of the 15 items correctly were considered to 
be ―cognitively impaired.‖ 
 
3.3.3. Lipid profile.  
Clinical laboratories involved in the blood analyses were certified by a national 
reference center of clinical chemistry that is a part of the Ministry of Health. These 
laboratories conduct internal reliability tests as part of their quality control procedures. In 
addition, blinded reliability analyses were conducted by the CRELES research team: 
Batches of 20 to 40 random samples were reanalyzed for each biomarker in a control 
 49 
laboratory. For all lipid analyses, correlations above 0.9 were found between laboratories. 
Systematic differences were found for HDL and triacylglyceride values from two clinical 
laboratories. In response, these values were adjusted with equations estimated by 
regression using the validation batches (Mendez-Chacon, Rosero-Bixby, Fernandez-
Rojas, & Barrantes-Jimenez, 2007). 
 
3.4 Analysis 
Collected data from CRELES are available to the public at the ICPSR, the 
National Archive of Computerized Data on Aging, and the National Institute of Aging’s 
website (ICPSR, 2010). Data are available for SPSS and SAS software and are divided 
into 10 data sets: anthropometry and mobility, biomarkers, diet, elderly people, 
household members, insurance, medications, non-resident children, pensions, and 
recoded variables. In addition to these files, this website provides questionnaire sets; 
information about weighing, sampling, and data collection procedures; and a codebook. 
The codebook includes variable names, variable types, missing values, ranges, and labels 
(e.i., 1= yes, 0 = no).  
Statistical analyses were conducted using IBM SPSS Statistics version 19 (IBM 
Corporation, Somers, NY, 2010). The first step was to identify which variables will be 
used from the nearly one nine hundred variables recorded. All data sets were revised 
once variables were identified; unneeded variables were dropped, and all necessary 
variables from different data sets were merged into a new file. In addition to variables 
related to the research questions, variables needed for data identification and analysis 
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(e.i., identification, health areas, non-response weight, and age) were included in the 
new database. To confirm to normality, tests of skew and kurtosis were conducted. 
Significance tests for skew and kurtosis were not used because, in large sample sizes, 
they are likely to be significant even when skew and kurtosis are not significantly 
different from normal (Field, 2010).  
To obtain nationally representative data, all descriptive statistical analyses were 
conducted while weighing for the variable ―ponderator‖ (Rosero-Bixby, Fernández, & 
Dow, 2005c). This sampling weight was used to correct for two factors: (1) 
oversampling of the oldest-old individual and (2) the higher non-response rate among 
younger men with high SES who are living in urban settings. The results provided data 
that replicate the structure by sex, age, urban residence, and education of the population 
of Costa Ricans born in 1945 or before and still living in 2005. 
General characteristics between cognitively disabled and non-cognitively disabled 
subjects were explored using descriptive statistics. T-test statistics were used to assess 
significant differences between means for age, years of schooling, and income. Chi 
square tests were conducted to compare categorical differences such as sex, residence, 
and previously diagnosed medical conditions (hypertension, diabetes, etc). When 
looking at the serum lipid profiles, data from participants using lipid-lowering 
medication were removed to avoid bias.  
The effects on cognitive health were examined using two cognitive health 
variables: cognitive scale and cognitive disability. The cognitive scale was standardized 
to scores between 0 and 100. The cognitive disability variable was dichotomized: 1 being 
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the absence of cognitive disability and 0 being the presence of cognitive disability. The 
cutoff point was inaccurately responding to fewer than 12 out of 15 (75%) of the items on 
the MMSE. A value of ―0‖ was assigned whenever the participant needed a proxy for the 
interview. 
In addition, new variables needed to be created using information from the data 
set. In the CRELES data set, fatty acid intake is reported in grams per day. When using 
this variable to compare energy intake, nutrients were adjusted by energy intake (Willet, 
1998). Fat intake was also intake examined as total energy and grams per day. Saturated, 
monounsaturated, polyunsaturated, and trans fatty acid variables reported in grams per 
day, were transformed into a calorie percentage using the following formula:  
 
Percentage of calories per dayi = [(Fati g/day * 9 kcal/g)* total calorie intakei]* 100 
 
For the linear regression models, variables were entered according to the potential 
influence each variable may have on the dependent variable according to findings from 
previous research. All variables found to be not significant (p> 0.05) were removed from 
the model. This model was controlled for age, caloric intake and lipid medication. In 
addition to the regression analysis, descriptive statistics (mean, standard deviation, and 
correlation), 95% confidence intervals, and an analysis of variance (ANOVA) were 
completed. A logic regression model was created to assess the relationship between these 
variables and the presence or absence of cognitive impairment.  
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CHAPTER FOUR 
ASSOCIATION BETWEEN NUTRTION, HEALTH INDICATORS AND COGNITIVE 
FUNCTION IN COSTA RICAN OLDER ADULTS 
In Preparation for Journal of Nutrition and Aging 
 
4.1 Introduction 
Older adults are among the fastest-growing segment of the world’s population. 
The number and proportion of this population is increasing in both developing and 
developed countries. In five years, the number of people aged 65 or older will outnumber 
children under the age of five (World Health Organization, National Institute of Aging & 
National Institute of Health, 2011). In Costa Rica, life expectancy is comparable to 
developed countries such as the United States and Western European countries. Of added 
importance to this comparison, is the fact that the Costa Rican gross national product 
(GNP) is a small fraction of the GNP for American or Western European countries 
(United Nations, 2009). Increases in longevity and the proportion of people over the age 
of 60 years are often regarded as a challenge to health systems as longer lives are 
commonly associated with an increased prevalence of disease (World Health 
Organization, 2000). The loss of cognitive capacity is one of the most important factors 
affecting the quality of life of older adults and their families. In addition, it is one of the 
main reasons that people are admitted into nursing homes (Gaugler, Duval, Anderson, & 
Kane, 2007). The causes of cognitive decline remain uncertain; however, it has been 
linked to cardiovascular disease and risk factors such as diabetes mellitus and high blood 
 55 
pressure (Naqvi et al., 2011). Dietary fatty acids play an important role in cardiovascular 
disease; thus, it is plausible that they could have a role in cognitive deterioration as well 
(Hunter, Zhang & Kris-Etherton, 2009). Fatty acids could be involved through several 
mechanisms, including atherosclerosis, thrombosis, and inflammation (Kalmijn, 2000). 
Increasing interest has emerged in the hypothesis that the consumption of fish, 
polyunsaturated fatty acids (PUFA), eicosapentaenoic acid (EPA) and docohexanoic acid 
DHA could play a protective role against cognitive decline. Several studies have 
suggested that an increase of saturated fats could have negative effects on cognitive 
health (Kalmijn, Feskens, Launer & Kromhout, 1997; Morris et al., 2003), while PUFA 
and MUFA may have a protective effect (Capurso et al., 2003; Solfrizzi et al., 1999).  
Still relatively few findings exist about the differentials and determinants of aging 
and longevity. Although research on the impact of diet on aging and longevity has been 
conducted in developed nations, little is known about the populations from developing 
countries. The purpose of this current research is to examine the association between fatty 
acid intake, lipid profile, and cognitive health in Costa Rican elders. We had the 
opportunity to examine these issues using data from the Costa Rican Longevity and 
Healthy Aging Study (CRELES, or Costa Rica Estudio de Longevidad y Envejecimiento 
Saludable) public use data files (Rosero-Bixby, Fernández & Dow, 2005a). 
 
4.2 Materials and Methods 
This is a cross-sectional secondary data analysis from CRELES’s public use data 
files (Rosero-Bixby et al., 2005a). CRELES is a nationally representative longitudinal 
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survey of health and socioeconomic indicators of Costa Rican residents ages 60 and over 
in 2005. The study design and data collection were conducted by the University of Costa 
Rica's Centro Centroamericano de Población (CCP) in collaboration with the Instituto de 
Investigaciones en Salud (INISA), with the support of the Wellcome Trust (grant 
072406). Additional collaborating public entities included the Costa Rican Office of 
Social Security (CCSS) and the National Council of Senior Citizens (CONAPAM). This 
study was approved by the Ethical Science Committee of the University of Costa Rica.  
 
4.2.1 Study population 
The sample was drawn from Costa Rican residents in the 2000 population census 
who were born in 1945 or before, with an over-sample of the oldest-old (ages 95 and 
over). The inclusion criteria required living in Costa Rica, regardless of nationality, and 
to birth date before 1946, meaning participants had to be 60 years or older at the time of 
the first interview. A random selection was made from the database of the Census of 
Population of 2000 (Insituto Nacional de Estadística y Censo, 2000). Sampling was 
stratified by five-year age groups, varying from 1% of the population born in 1941-1945 
up to 100% of the population born before 1905 (over 95 years old at the time of the first 
data collection round). The no-answer rates can be classified as following: 19% of people 
deceased by date of contact, 18% of people could not be located (mostly due to the 
inaccurate addresses), 2% had changed residence and 4% declined to be interviewed. 
From those who were interviewed, 95% gave a blood sample, 92% gave a urine sample 
and almost 25% of all subjects needed a proxy (usually a close relative). 
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4.2.3 Data collection 
Baseline household interviews were conducted between November 2004 and 
September 2006, with two-year follow-up interviews. A field team of five interviewers, 
two phlebotomists and a field supervisor collected the information and the blood and 
urine specimens using a continuous fieldwork design over a period of nearly 2 years. All 
data and specimens in the study were collected at the participants' homes, usually during 
two visits. They were collected using personal digital assistants (PDAs), also known as 
palm computers, with software applications developed by CCP for this study. During the 
first visit, participants provided informed consent and answered a 90 minute long 
questionnaire. During a second visit, which was typically held early in the morning the 
day after the initial inerview, urine samples, blood samples and anthropometric measures 
were collected by trained personnel (Rosero-Bixby, Fernández & Dow, 2005b). 
Information on the participants’ diet was collected using a previously validated 
Food Frequency Questionnaire (FFQ) (Campos et al., 1991). This is a semi-quantitative 
questionnaire based the Willett et al’s (1984) questionnaire, developed specifically for 
Costa Rican populations (Campos et al., 1991). The questionnaire asks for the average 
consumption during the previous year (prior to the day of the survey). The nine options to 
categorize consumption frequency are a range from "never‖ or ―less than once a month" 
up to "6 or more times a day‖. Information about vitamins and nutritional supplements as 
well as type of fat or oil  used most frequently for cooking (shortening, margarine, etc.) at 
home was also requested. For each individual, energy and nutrient intake were calculated 
by multiplying the frequency of consumption of each food by the nutritional content of 
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the respective portion. Using stepwise regression, CRELES researchers reduced the 
original FFQ to an abbreviated version, identifying 27 tracer foods in addition to the type 
of oil used for cooking. This process resulted in information on the nutrients of greater 
interest and the ability to reduce the interview time.  
Cognitive disability was assessed with a 15-item scale (Cronbach alpha = 0.72) 
adaptation of the Mini-Mental State Examination (MMSE) (Folstein, Folstein & 
McHugh, 1975; Quiroga, Albala, & Klaasen, 2004; Rosero-Bixby & Dow, 2009). 
Participants who answered fewer than 75% of the 15 items correctly were considered to 
be ―cognitively impaired.‖  
Clinical laboratories involved in the blood analyses were certified by a national 
reference center of clinical chemistry that is a part of the Ministry of Health. These 
laboratories conduct internal reliability tests as part of their quality control procedures. In 
addition, blinded reliability analyses were conducted by the CRELES research team. For 
this, batches of 20 to 40 random samples were reanalyzed for each biomarker in a control 
laboratory. For all lipid analyses, correlations above 0.9 were found between laboratories. 
Systematic differences were found for HDL and triacylglyceride values from two clinical 
laboratories. In response, these values were adjusted with equations estimated by 
regression using the validation batches (Mendez-Chacon, Rosero-Bixby, Fernandez-
Rojas & Barrantes-Jimenez, 2007). 
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4.2.4 Statistical Data 
Statistical analysis was conducted using IBM SPSS Statistics version 19 (IBM, 
2010). The effects on cognitive health were examined on two cognitive health variables: 
cognitive scale and cognitive impairment. The cognitive scale was standardized to 
scores between 0 and 100. The cognitive impairment variable was dichotomized, with 1 
being the absence of cognitive impairment and 0 being the presence of cognitive 
impairment. The cutoff point was inaccurately responding to fewer than 12 out of 15 
(75%) of the items on the MMSE. A value of ―0‖ was assigned whenever the subject 
needed a proxy for the interview.   
To obtain nationally representative data, all descriptive statistical analyses were 
conducted weighting for the variable ―ponderator‖ (Rosero-Bixby, Fernández & Dow, 
2005c). This sampling weight will correct for two factors: (1) oversampling of the 
oldest-old individuals and (2) the higher non-response rate among younger men with 
high SES and who are living in urban settings. General characteristics between 
cognitively disabled and non-cognitively disabled participants were explored using 
descriptive statistics. T-test statistics were used to assess significant differences between 
means for age, years of schooling and income. Chi square tests were conducted to 
compare categorical differences such as sex, residence and previously medically 
diagnosed conditions (hypertension, diabetes, etc). In terms of the lipid profiles, data 
from subjects using lipid lowering medication was removed to avoid bias. 
For the regression models, variables were entered according to the potential 
influence they may have over the dependent variable according to findings from 
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previous research. All variables found not to be significant (p> 0.05) were removed from 
the model. The model was controlled for age, caloric intake, lipid medication, and 
stroke. In addition to the regression analysis, descriptive statistics, 95% confidence 
intervals, and analysis of variance (ANOVA) were completed.  
 
4.3 Results 
As shown in Table 4.1, the study population has a mean age of 70.5 years. Highly 
significant differences (p<0.01) were found between mean ages from cognitively disabled 
and non-cognitively disabled adults. The cognitively disabled population included a 
greater percentage of women (p<0.05). No relevant differences were found in living 
settings. For all cases, more than half of the participants were living within the Great 
Metropolitan Area (GMA), which includes the city of San Jose and surrounding 
metropolitan areas (406km
2
). Most of the population reported some years of elementary 
education. Noteworthy differences were found in years of education, where the 
cognitively disabled population reported a smaller average of school years (p<0.01).  
Important differences were also found in monthly income; cognitively disabled 
participants presented a low mean monthly income in comparison to the non-cognitively 
disabled.  In addition, the majority of the cognitively disabled population was found to 
have an income below the poverty line (less than US$100/month) (p<0.01), whereas for 
the general study population and the non-cognitively disabled one third fell below the 
poverty line.  
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Table 4.1 General Characteristics of the CRELES Study Participants
a
 
Characteristics 
CRELES 
(n=2827) 
Cognitive Disability  
p-
value 
Yes  
(n=314) 
No 
 (n=2505) 
Men (%) 47.5 41.1 48.3 .017* 
Age (years) 70.5 (±8.1) 79.1 (±9.5) 69.37 (±7.2) .000** 
60-69 (%) 53.5 17.8 58.3  
70-79 (%) 32.0 33.5 31.3  
≥80 (%) 15 48.7 10.4  
Living in GMA (%) 53.0 51.1 53.2 .473 
Education (years)  5.2 (±4.2) 2.8 (±3.3) 5.5 (±4.2) .000** 
No formal education (%) 13.7 33.7 11.2  
Elementary (%) 
(1
st
- 6
th
 grade) 
64.8 59.6 65.4  
High school education (%)  
(7
th
-11
th
 grade)   
11.9 3.5 13.0  
Higher education (%) 9.6 3.2 10.4  
Monthly income  (US$) 458.8 
(±1332.9) 
186.8 
(±346.6) 
493.0 
(±1394.3) 
.000** 
<US$100/month (%)  39.0 56.3 36.9  
US$100 - US$399/month (%) 41.8 33.8 36.8  
>$399/month (%) 19.2 9.9 26.3  
a
Missing values weighted 
* p<0.05       **p<0.01 
 
General health information evidenced a more positive health profile for non-
cognitively disabled participants (Table 4.2). Statistical significance differences were 
found in the ratio of cognitively disabled elders who had been medically diagnosed with 
stroke and heart attack (p<0.01), and other heart conditions (p<0.05). A higher 
percentage of elders without cognitive disability reported a diagnosis of dyslipidemia 
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(p<0.01). Metabolic syndrome and BMI were also found to be higher among the non-
cognitively impaired (p<0.001); however, these variables are not medical diagnoses but 
outcomes calculated from collected biomarkers and anthropometric measurements.  
 
Table 4.2 General Health Characteristics of the CRELES Study Participants
a
 
Characteristics 
CRELES 
(n=2827) 
Cognitive Disability 
p-
value 
Yes  
(n=314) 
No 
 (n=2505) 
Diagnosed conditions      
Hypertension (%) 48.2 51.2 47.9 .214 
High Cholesterol (%) 39.1 29.1 40.3 .000** 
Diabetes (%) 20.8 21.8 20.6 .566 
Stroke (%) 3.8 15.9 2.3 .000** 
Heart attack (%) 4.6 8.1 4.1 .009** 
Other heart conditions (%) 12.0 17.0 11.4 .013* 
Metabolic syndrome (%) 47.1 39.0 48.0 .006** 
Mean Weight (lbs) 145.5 
(±30.4) 
129.4 
(±31.1) 
147.2 
(±29.9) 
.000** 
Mean BMI (kg/m
2
) 26.9 (±5.2) 24.8 (±5.4) 27.1 (±5.2) .000** 
a
Missing values weighted 
*p<0.05       **p<0.01 
 
 Differences in BMI are also reflected in all four BMI categories (WHO, 2002). 
As shown in Figure 4.1, the percentage of cognitively disabled older adults classified as 
underweight and normal is significantly higher than non-cognitively disabled (p<0.010). 
Furthermore, the percentage of non-cognitively disabled older adults classified as 
overweight and obese is significantly larger than the cognitive disabled (p<0.010). 
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* p<0.05 ** p<0.01 
Figure 4.1 BMI classification and cognitive disability 
 
When comparing energy and macronutrient intake between those considered 
cognitively disabled (<75% right answers in the MMSE) and those who are not (Table 
4.3), energy and MUFA were greater in the latter group (p<0.01 and p<0.05 
respectively). TFA intake was higher in participants with cognitive disability (p<0.01). 
No significant differences were found in protein and dietary cholesterol intake between 
groups.  
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Table 4.3 Dietary Intake in Relation to Cognitive Disability
ab
 
Nutrient 
Cognitive Disability  (mean  ±SD) 
t-test 
Yes (n=314) No (n=2505) 
Energy (kcal) 1983.84 ±718.13 2178.47 ±730.72 .000** 
Protein (g) 70.55 ±9.32 69.96 ±9.61 .284 
Carbohydrates (g) 308.43 ±29.56 307.82 ±35.63 .738 
Total Fat (g) 74.09 ±10.64 74.70 ±14.23 .369 
Dietary Cholesterol (mg) 253.93 ±104.10 246.01 ±110.88 .230 
SFA (g) 27.67 ±7.17 26.89 ±7.48 .080 
MUFA (g) 24.16 ±7.79 25.35 ±11.01 .016* 
PUFA (g) 18.22 ±5.38 18.62 ±5.32 .207 
n-6 PUFA (g) 16.23 ±4.98 16.64 ±4.96 .203 
n-3 PUFA (g) 1.92 ±.61 1.95 ±.61 .441 
TFA (g) 3.16 ±.89 2.97 ±.95 .001** 
a 
Missing values weighted 
b 
Nutrients adjusted for energy intake. 
* p<0.05       ** p<0.01 
 
 Figure 4.2 compares differences in energy and macronutrient intake between 
cognitively disabled and non-cognitively disabled participants. Energy, total fat, and 
MUFA intake were significantly greater in non- cognitively disable subjects (p<0.01). No 
significant differences were found in SFA, TFA and PUFA intake.  
 
 65 
 
* p<0.05 ** p<0.01  
Figure 4.2 Fat intakes and cognitive disability 
 
The lipid profile from cognitively disabled individuals was compared to the lipid 
profile of that of non-cognitively disabled. Non-cognitively disabled individuals were 
grouped according to their use of lipid medications. Only one cognitively disabled elder 
reported using lipid medication. (Figure 4.3).  
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TC = Total Cholesterol TAG = Triacylglyderides 
* p<0.05 ** p<0.01  
Figure 4.3 Serum lipid profile and cognitive disability 
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Contrary to our expectations, the lipid profile of non-cognitively impaired  
participants who were not taking lipid medications was more detrimental; total 
cholesterol, LDL, and triglycerides were significantly higher in this population (p<0.01) 
than their cognitively impaired counter parts. No noteworthy differences were found in 
HDL. No significant differences were found between those who reported taking lipid 
medications and those who did not.  
The linear regression analysis was done using the scale of cognitive performance 
as the outcome variables, adjusting for age and lipid medication (Table 4.4). This scale 
was based on MMSE results, with 100 representing a good outcome and 0 an undesired 
outcome. Participants who required a proxy during the interview were automatically 
assigned a score of 0. The model chosen presented an R
2
=0.299 and a significance of 
0.000, meaning 29% of the variance can be explained by this model. A positive 
association was found with total fat intake (β coefficient = 3.9, p<0.01), n-6 PUFA (β 
coefficient = 1.336, p<0.05) and n-3 PUFA (β coefficient = .221 p<0.05). In contrast, 
PUFA, MUFA, SFA and TFA were found to be negatively associated (p<0.01) with 
MMSE score. Total serum cholesterol was negatively associated with cognitive scale 
performance and n-6 PUFA (β coefficient = -1.754, p<0.01), while HDL, LDL, and 
triacylglyceride (TAG) were found to bepositively associated with a better performance 
on the MMSE (p<0.01).  
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Table 4.4 Linear regression analysis of dietary fat and intake and serum lipids as 
predictors of MMSE score. 
Variables 
Linear Regression Model (R
2
 = .299 p<0.001) 
β Coefficient 
95% CI 
p-value 
Lower Upper 
Total Fat (%) 3.944 3.485 15.334 .002** 
PUFA (%) -3.389 -26.655 -5.157 .004** 
MUFA (%) -2.623 -15.180 -3.298 .002** 
SFA (%) -2.505 -15.417 -3.341 .002** 
Total Cholesterol (mg/dL) -1.754 -.724 -.176 .001** 
LDL (mg/dL) 1.564 .189 .737 .001** 
n-6 PUFA (%) 1.336 -.003 13.455 .050 
HDL (mg/dL) .486 .162 .678 .001** 
TFA (%) -.471 -19.210 -5.761 .000** 
TAG(mg/dL) .461 .044 .155 .000** 
n-3 PUFA (%) .221 1.780 16.449 .015* 
TC = Total Cholesterol TAG = Triacylglyderides 
* p<0.05 ** p<0.01  
 
 Table 4.5 shows the logistic regression using the absence or presence of cognitive 
disability as the outcome variable.  Several models were proposed; however, the only 
model that showed statistical significance for both the model and variables included total 
fat and total cholesterol variables only. Total fat intake presented an odds ratio of .970 
(p<0.050). As total fat intake increases, the odds of being cognitively disabled decreases. 
In contrast, the total serum cholesterol odds ratio was 1.996 (p<0.010); thus, as serum 
cholesterol increases, the chance of cognitive impairment doubles.    
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Table 4.5 Logistic regression correlated of dietary fat intake and serum cholesterol as 
predictors of cognitive disability  
Variables 
Logistic Regression Model  
(Nagelkerke R
2
 = .331 p<0.000) 
Odds Ratio 
95% CI 
p-value 
Lower Upper 
Total Fat (%) .970 .947 .993 .010* 
Total Cholesterol (mg/dL) 1.996 1.993 1.998 .001** 
* p<0.05 ** p<0.01  
 
 
4.4 Discussion 
 This study found highly significant differences between cognitively disabled and 
non-cognitively disabled older adults. Demographic data showed that adults who scored 
less than 75% on the MMSE were younger, had lower income, and had fewer years of 
formal education. Important differences were also found in the health profile. Medical 
diagnoses of diabetes, stroke, and heart attack were significantly higher among the 
cognitively disabled. Non-cognitively disabled adults had a higher rate of medical 
diagnosis of dyslipidemia and presented a higher rate of metabolic syndrome according to 
study samples and data. Anthropometric data confirmed that cognitively disabled elders 
had a lower BMI, lower body weight, and a higher percentage of underweight.  Dietary 
analysis revealed a lower energy, total fat and MUFA intake in comparison to their 
counterparts. Lipid profile of non-cognitively disabled adults exposed significantly higher 
levels of LDL, triacylglycerides and total cholesterol. The multiple regression analysis 
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suggested a significant (p<.050), yet weak (R
2
=.299), association between MMSE score 
and serum lipid profile and dietary fatty acids (β coefficients <3.9).  
Confidence in these findings is strengthened by the following factors. The study 
included a large population-based sample, increasing the external validity of the findings. 
Diet and cognitive health were assessed using previously validated instruments, that have 
been widely used in epidemiological studies. Statistical analyses were controlled for age, 
caloric intake, and the use of lipid medications.  
 The sample of cognitively disabled adults was older and included more women, 
which likely stems from the fact that women’s life expectancy is higher than men’s and 
the risk of dementia increases sharply with age (World Health Organization, National 
Institute of Aging & National Institute of Health, 2011). Cognitively disabled subjects 
also reported lower education, suggesting that education may be a protective factor 
against cognitive decline. Results from previous research on education and cognitive 
decline are controversial. In their literature review, Anstey and Christensen (2000), 
implied that most studies usinf the MMSE, which measures crystallized cognition 
(vocabulary, general knowledge), found a negative association between education and 
cognitive decline; meanwhile studies using fluid measures of cognitive health (pattern 
recognition, abstract reasoning, and problem-solving) did not find such associations 
(Anstey & Christensen, 2000). Furthermore, results from an 8-year population-based 
study concluded that education does not appear to protect against cognitive decline, but 
when using the MMSE, less educated individuals may be diagnosed with dementia earlier 
(Muniz-Terrera, Matthews, Dening, Huppert & Brayne, 2009). The MMSE is a reliable 
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tool for measuring cognitive health; however, it does not assess the type of cognitive 
dysfunction. Some conditions such as Alzheimer’s disease, stroke or ischemic dementia 
have been linked with lifestyle and health choices (Luchsinder & Mayeux, 2004; 
Solfrizzi, Panza & Capurso, 2003) whereas others, such as traumatic brain injury, are not. 
This same confounder could apply to the differences found in monthly income, 
where almost half of the cognitively impaired adults were found to be living under the 
poverty line (<US$100/month). Nevertheless, a robust body of literature supports the 
association between socioeconomic status and health association may continue into old 
age, although gradients appear smaller at older ages (Crimmins, 2005; Turra & Goldman, 
2007). 
The prevalence of high cholesterol being greater in the non-cognitively disabled 
adults contradicts previous findings. First, dyslipidemia risk increases with age (Grundy 
et al., 2011); the older adults in this group are on average younger than the cognitively 
disabled participants. Second, high cholesterol is increasingly recognized as a risk factor 
for ischemic stroke, silent ischemic white-matter lesions, and vascular dementia 
(Kivipeltp et al., 2001; Launer et al., 2000; Skoog et al., 1996). These results can be 
attributed to the fact that high cholesterol was self-reported and is frequently undiagnosed 
(Grundy et al., 2011); highlighting the limitation of the self-reported nature of the 
CRELES information which might be affected by reporting bias. 
Cognitively impaired participants presented lower body weight, lower BMI, and 
lower metabolic syndrome prevalence. Furthermore, more cognitively impaired adults 
were classified as underweight and normal than their counterparts. It is possible that these 
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differences can be attributed to changes in diet and lifestyle due to the cognitive 
impairment which may interfere with their access to foods, ability to prepare their own 
meals and ability to chew and/or swallow certain foods. These assumptions could also 
explain the differences found in the dietary analysis and serum lipid profile.   
Large population-based studies have examined dietary intake and serum lipid 
profile; however, results have been conflicting. In France, Pradignac, Schlienger, Velten, 
and Mejean (1995) found a positive relationship between fatty acid intake and the MMSE 
in women. A similar study in Spain found that participants with adequate scores on the 
MMSE (>28 pts) had lower intake of SFA, MUFA and cholesterol (Ortega et al., 1997). 
The Italian Longitudinal Study on Aging indicated an inverse relationship between 
MUFA and PUFA, and cognitive decline (Solfrizzi et al., 2006).  
Contrasting results were found by van de Rest et al (2008) in a similar study 
conducted in the United States. Their study used a battery of tests including MMSE, 
memory tests, language test, perceptual speed and attention with 1,025 elderly men. A 
Ccross-sectional analysis found no association between fatty fish or PUFA (van de Rest 
et al., 2008).  
Results from Conquer et al (2000), point in the opposite direction, suggesting that 
low levels of n-3 fatty acids in the plasma may be a risk factor for cognitive impairment, 
Alzheimer’s disease, and/or dementia. However, statistical analyses from their study do 
not consider confounding factors, such as age and educational level. Another limitation is 
that no dietary intakes or histories were done; therefore, it is unclear if the participants 
consumed at the time or in the past, diets that were lower in PUFAs.  
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One important limitation of the current study is the fact that this is cross-sectional 
analysis and cannot address cause-and-effect relationships, namely, cognitive disability 
affecting dietary intake or dietary intake affecting cognitive disability. The use of FFQs 
for dietary assessment include restrictions imposed by a fixed list of foods based on 
relatively few diet constituents, reliance on memory, perception of portion sizes, and 
interpretation of questions.  In addition, there is no data on the validity of the FFQ in 
cognitively impaired subjects, and some of the cognitively disabled individuals needed a 
proxy for the interview who may or may not have been fully aware of the personal 
history (eg. years of formal education) or dietary intake of the participant. Furthermore, 
cognition in the elderly is believed to be shaped by long-term exposures (Launer, 2005). 
In conclusion, differences in demographic, health, and diet characteristics 
emerged between cognitively disabled Costa Rican elders and their counterparts. Dietary 
fat intake and serum lipid profile are weakly associated with cognitive outcomes. Further 
research, particularly longitudinal studies, are needed to better examine this relationship. 
Finally, residual confounding by unknown risk factors is possible, such as a generally 
healthier lifestyle of individuals with better dietary intake, which may play an important 
role in altering the outcomes. Such possibility cannot be excluded.  
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Appendix C 
Clemson University Office of Research Compliance (ORC) Review 
Dear Catalina and Katherine, 
  
The Clemson University Office of Research Compliance (ORC) has determined that the 
project identified above does not involve human subjects as defined in the Federal 
regulations governing the protection of human subjects in research [45 CFR 46.102(f)] 
and is, therefore, not subject to IRB review. 
As per our conversation this afternoon and my review of the website from which the 
CRELES data are available 
(http://www.icpsr.umich.edu/icpsrweb/NACDA/studies/26681?archive=NACDA&q=crel
es), at this time, this project will not involve either ―intervention or interaction‖ with 
living individuals, or the collection or use of ―identifiable private information‖ about 
living individuals. Therefore, IRB review is not required. 
Please contact this office again if there are any changes to this project that might bring it 
under the purview of the IRB. It is the responsibility of the ORC to determine whether 
any specific research project falls within the definition of research with human subjects, 
as provided by Federal regulations and institutional policy. 
Thank you for contacting us to check on whether your project required IRB review and 
approval. 
Good luck with this project and please feel free to contact me if you have any questions. 
  
Best, 
  
Laura 
 
